Search Name:	V20130429-04 BS p197-2 wt1/results1
			V20130429-04 BS p197-2 wt1/results1																					
	Uniq Pep	Acc #	UniProt ID	Gene	Num Unique	% Cov	Best Disc Score	Best Expect Val	m/z	z	ppm	DB Peptide	Peptide	Protein Mods	Length	Fraction	RT	Start	End	Score	Expect	P Value	# in DB	Protein MW	Species	Protein Name
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	845.4086	3	-0.27	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-04_FTMSms2hcd	53.960	85	107	49.2	1.2e-17	1.1e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	865.7938	3	2.7	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-04_FTMSms2hcd	71.042	163	186	48.1	5.8e-17	1.3e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	1147.0219	2	1.6	WGDAGAEYVVESTGVFTTMEK	WGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	21	V20130429-04_FTMSms2hcd	53.705	87	107	45.8	1.5e-16	1.5e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	742.1170	4	0.93	VIISAPSADAPMFVMGVNHEKYDNSLK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	27	V20130429-04_FTMSms2hcd	42.836	119	145	48.9	2.9e-15	3.0e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	871.1233	3	0.19	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-04_FTMSms2hcd	61.899	163	186	53.9	3.2e-15	5.3e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	756.0632	3	3.0	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-04_FTMSms2hcd	52.784	228	248	44.9	1.5e-14	2.3e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	847.4528	3	-1.1	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-04_FTMSms2hcd	48.543	62	84	53.8	2.0e-14	4.2e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	882.4059	2	1.2	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-04_FTMSms2hcd	49.604	310	323	54.9	3.3e-14	3.7e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	1004.7285	4	1.0	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	35	V20130429-04_FTMSms2hcd	68.872	21	55	44.9	3.7e-14	4.2e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	681.0405	3	-0.35	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-04_FTMSms2hcd	52.345	67	84	49.1	8.8e-13	2.2e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	737.3912	2	1.4	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-04_FTMSms2hcd	43.439	235	248	40.4	9.5e-11	1.5e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	454.8837	3	-1.9	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-04_FTMSms2hcd	16.108	324	335	33.5	3.7e-10	4.9e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	749.0388	3	1.2	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-04_FTMSms2hcd	41.426	119	139	21.9	2.0e-9	2.2e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	970.2629	5	-6.8	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK		46	V20130429-04_FTMSms2hcd	58.965	264	309	36.2	3.2e-9	5.1e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	706.3988	2	-0.022	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-04_FTMSms2hcd	38.779	201	215	31.9	4.0e-8	1.1e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	362.7100	4	1.8	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-04_FTMSms2hcd	14.139	249	260	31.4	2.1e-7	6.4e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	403.2196	2	0.51	VGVNGFGR	VGVNGFGR		8	V20130429-04_FTMSms2hcd	22.194	6	13	36.7	6.2e-7	1.2e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	18	80.0	9.86	1.2e-17	435.2572	2	-2.3	VIPELNGK	VIPELNGK		8	V20130429-04_FTMSms2hcd	24.748	220	227	28.9	8.1e-6	3.5e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	918.9246	2	3.6	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-04_FTMSms2hcd	60.567	1	18	53.8	5.7e-22	6.3e-25	1	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	790.9042	2	-0.71	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-04_FTMSms2hcd	22.993	313	326	54.4	4.1e-17	5.3e-20	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	239	254	53.5	5.4e-13	6.4e-16	10	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	800.6578	4	0.045	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-04_FTMSms2hcd	53.430	148	177	38.0	6.5e-13	8.4e-16	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	677.8155	2	0.28	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-04_FTMSms2hcd	11.800	51	62	49.5	6.7e-13	8.7e-16	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	977.5370	2	1.2	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-04_FTMSms2hcd	41.026	96	113	49.6	5.6e-12	1.5e-14	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	589.3091	2	-2.0	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-04_FTMSms2hcd	24.911	316	326	38.4	2.8e-11	4.1e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	1116.0360	2	-0.068	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-04_FTMSms2hcd	48.089	292	312	41.5	2.7e-10	2.6e-13	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	599.7642	2	-0.93	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-04_FTMSms2hcd	13.169	51	61	39.6	7.4e-9	1.5e-11	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	29	39	42.4	1.2e-8	4.3e-11	9	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	635.5475	4	0.70	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-04_FTMSms2hcd	17.619	40	62	20.9	1.5e-7	1.5e-10	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	1042.1600	3	5.6	CDVDIRKDLYANTVLSGGTTMYPGIADR	CDVDIRKDLYANTVLSGGT(Phospho)TMYPGIADR	Phospho@297|300|303|304	28	V20130429-04_FTMSms2hcd	50.942	285	312	19.3	1.1e-4	1.0e-7	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-04_FTMSms2hcd	47.648	178	191	13.6	6.1e-4	6.6e-7	7	41793.2	HUMAN	Actin, cytoplasmic 2
[2]		P63261	ACTG_HUMAN	ACTG1	14	47.5	12.19	5.7e-22	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	62	68	17.9	0.018	1.1e-4	10	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	890.8925	2	2.8	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-04_FTMSms2hcd	52.384	1	18	50.4	1.1e-20	1.4e-23	1	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	790.9042	2	-0.71	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-04_FTMSms2hcd	22.993	313	326	54.4	4.1e-17	5.3e-20	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	239	254	53.5	5.4e-13	6.4e-16	10	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	800.6578	4	0.045	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-04_FTMSms2hcd	53.430	148	177	38.0	6.5e-13	8.4e-16	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	677.8155	2	0.28	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-04_FTMSms2hcd	11.800	51	62	49.5	6.7e-13	8.7e-16	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	977.5370	2	1.2	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-04_FTMSms2hcd	41.026	96	113	49.6	5.6e-12	1.5e-14	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	589.3091	2	-2.0	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-04_FTMSms2hcd	24.911	316	326	38.4	2.8e-11	4.1e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	1116.0360	2	-0.068	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-04_FTMSms2hcd	48.089	292	312	41.5	2.7e-10	2.6e-13	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	599.7642	2	-0.93	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-04_FTMSms2hcd	13.169	51	61	39.6	7.4e-9	1.5e-11	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	29	39	42.4	1.2e-8	4.3e-11	9	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	635.5475	4	0.70	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-04_FTMSms2hcd	17.619	40	62	20.9	1.5e-7	1.5e-10	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	1042.1600	3	5.6	CDVDIRKDLYANTVLSGGTTMYPGIADR	CDVDIRKDLYANTVLSGGT(Phospho)TMYPGIADR	Phospho@297|300|303|304	28	V20130429-04_FTMSms2hcd	50.942	285	312	19.3	1.1e-4	1.0e-7	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-04_FTMSms2hcd	47.648	178	191	13.6	6.1e-4	6.6e-7	7	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P60709	ACTB_HUMAN	ACTB	14	47.5	11.50	1.1e-20	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	62	68	17.9	0.018	1.1e-4	10	41737.1	HUMAN	Actin, cytoplasmic 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	790.9042	2	-0.71	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-04_FTMSms2hcd	22.993	315	328	54.4	4.1e-17	5.3e-20	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	241	256	53.5	5.4e-13	6.4e-16	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	677.8155	2	0.28	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-04_FTMSms2hcd	11.800	53	64	49.5	6.7e-13	8.7e-16	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	589.3091	2	-2.0	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-04_FTMSms2hcd	24.911	318	328	38.4	2.8e-11	4.1e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	695.5323	5	-1.4	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-04_FTMSms2hcd	53.761	71	97	34.0	1.5e-9	1.4e-12	2	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	599.7642	2	-0.93	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-04_FTMSms2hcd	13.169	53	63	39.6	7.4e-9	1.5e-11	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	31	41	42.4	1.2e-8	4.3e-11	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	635.5475	4	0.70	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-04_FTMSms2hcd	17.619	42	64	20.9	1.5e-7	1.5e-10	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	1049.8043	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=29	28	V20130429-04_FTMSms2hcd	59.314	259	286	16.3	4.4e-5	4.3e-8	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-04_FTMSms2hcd	47.648	180	193	13.6	6.1e-4	6.6e-7	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	2	P68032	ACTC_HUMAN	ACTC1	11	36.9	9.57	4.1e-17	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	64	70	17.9	0.018	1.1e-4	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	790.9042	2	-0.71	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-04_FTMSms2hcd	22.993	315	328	54.4	4.1e-17	5.3e-20	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	241	256	53.5	5.4e-13	6.4e-16	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	677.8155	2	0.28	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-04_FTMSms2hcd	11.800	53	64	49.5	6.7e-13	8.7e-16	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	589.3091	2	-2.0	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-04_FTMSms2hcd	24.911	318	328	38.4	2.8e-11	4.1e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	695.5323	5	-1.4	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-04_FTMSms2hcd	53.761	71	97	34.0	1.5e-9	1.4e-12	2	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	599.7642	2	-0.93	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-04_FTMSms2hcd	13.169	53	63	39.6	7.4e-9	1.5e-11	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	31	41	42.4	1.2e-8	4.3e-11	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	635.5475	4	0.70	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-04_FTMSms2hcd	17.619	42	64	20.9	1.5e-7	1.5e-10	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	1049.8043	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=29	28	V20130429-04_FTMSms2hcd	59.314	259	286	16.3	4.4e-5	4.3e-8	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-04_FTMSms2hcd	47.648	180	193	13.6	6.1e-4	6.6e-7	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	2	P68133	ACTS_HUMAN	ACTA1	11	36.9	9.57	4.1e-17	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	64	70	17.9	0.018	1.1e-4	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	790.9042	2	-0.71	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-04_FTMSms2hcd	22.993	314	327	54.4	4.1e-17	5.3e-20	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	240	255	53.5	5.4e-13	6.4e-16	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	677.8155	2	0.28	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-04_FTMSms2hcd	11.800	52	63	49.5	6.7e-13	8.7e-16	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	589.3091	2	-2.0	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-04_FTMSms2hcd	24.911	317	327	38.4	2.8e-11	4.1e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	599.7642	2	-0.93	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-04_FTMSms2hcd	13.169	52	62	39.6	7.4e-9	1.5e-11	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	30	40	42.4	1.2e-8	4.3e-11	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	635.5475	4	0.70	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@45;Oxidation@48	23	V20130429-04_FTMSms2hcd	17.619	41	63	20.9	1.5e-7	1.5e-10	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	853.0211	5	-1.5	YSVWIGGSILASLSTFQQMWISKPEYDEAGPSIVHRK	YSVWIGGSILASLSTFQQMWIS(Phospho)KPEYDEAGPSIVHRK	Phospho@338|339|345|349|351|352|359|363	37	V20130429-04_FTMSms2hcd	75.161	338	374	12.1	4.0e-5	5.5e-8	1	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	1049.8043	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=29	28	V20130429-04_FTMSms2hcd	59.314	258	285	16.3	4.4e-5	4.3e-8	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-04_FTMSms2hcd	47.648	179	192	13.6	6.1e-4	6.6e-7	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-4]	2	P63267	ACTH_HUMAN	ACTG2	11	39.6	9.57	4.1e-17	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	63	69	17.9	0.018	1.1e-4	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	790.9042	2	-0.71	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-04_FTMSms2hcd	22.993	315	328	54.4	4.1e-17	5.3e-20	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	241	256	53.5	5.4e-13	6.4e-16	10	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	677.8155	2	0.28	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-04_FTMSms2hcd	11.800	53	64	49.5	6.7e-13	8.7e-16	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	589.3091	2	-2.0	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-04_FTMSms2hcd	24.911	318	328	38.4	2.8e-11	4.1e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	599.7642	2	-0.93	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-04_FTMSms2hcd	13.169	53	63	39.6	7.4e-9	1.5e-11	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	31	41	42.4	1.2e-8	4.3e-11	9	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	635.5475	4	0.70	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-04_FTMSms2hcd	17.619	42	64	20.9	1.5e-7	1.5e-10	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	1049.8043	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=29	28	V20130429-04_FTMSms2hcd	59.314	259	286	16.3	4.4e-5	4.3e-8	4	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-04_FTMSms2hcd	47.648	180	193	13.6	6.1e-4	6.6e-7	7	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P62736	ACTA_HUMAN	ACTA2	10	29.7	9.57	4.1e-17	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	64	70	17.9	0.018	1.1e-4	10	42009.4	HUMAN	Actin, aortic smooth muscle
[2-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	4	4.8	7.34	5.4e-13	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	939	954	53.5	5.4e-13	6.4e-16	10	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	4	4.8	7.34	5.4e-13	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	729	739	42.4	1.2e-8	4.3e-11	9	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	4	4.8	7.34	5.4e-13	656.6866	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-04_FTMSms2hcd	41.065	796	813	20.9	5.6e-7	1.1e-9	4	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	4	4.8	7.34	5.4e-13	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	762	768	17.9	0.018	1.1e-4	10	121364.6	HUMAN	POTE ankyrin domain family member E
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.2	7.34	5.4e-13	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	939	954	53.5	5.4e-13	6.4e-16	10	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.2	7.34	5.4e-13	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	729	739	42.4	1.2e-8	4.3e-11	9	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.2	7.34	5.4e-13	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	762	768	17.9	0.018	1.1e-4	10	121445.7	HUMAN	POTE ankyrin domain family member F
[2-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	2	9.1	7.34	5.4e-13	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	239	254	53.5	5.4e-13	6.4e-16	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	2	9.1	7.34	5.4e-13	656.6866	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-04_FTMSms2hcd	41.065	96	113	20.9	5.6e-7	1.1e-9	4	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-9]	1	P0CG38	POTEI_HUMAN	POTEI	3	3.3	4.99	1.2e-8	400.2396	3	-1.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-04_FTMSms2hcd	35.230	729	739	42.4	1.2e-8	4.3e-11	9	121283.5	HUMAN	POTE ankyrin domain family member I
[2-9]	1	P0CG38	POTEI_HUMAN	POTEI	3	3.3	4.99	1.2e-8	656.6866	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-04_FTMSms2hcd	41.065	796	813	20.9	5.6e-7	1.1e-9	4	121283.5	HUMAN	POTE ankyrin domain family member I
[2-9]	1	P0CG38	POTEI_HUMAN	POTEI	3	3.3	4.99	1.2e-8	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-04_FTMSms2hcd	25.407	762	768	17.9	0.018	1.1e-4	10	121283.5	HUMAN	POTE ankyrin domain family member I
[2-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	2	8.0	7.34	5.4e-13	895.9498	2	0.23	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-04_FTMSms2hcd	47.887	240	255	53.5	5.4e-13	6.4e-16	10	42003.6	HUMAN	Beta-actin-like protein 2
[2-10]	0	Q562R1	ACTBL_HUMAN	ACTBL2	2	8.0	7.34	5.4e-13	820.4100	2	-14	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-04_FTMSms2hcd	47.648	179	192	13.6	6.1e-4	6.6e-7	7	42003.6	HUMAN	Beta-actin-like protein 2
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	995.8040	3	1.1	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-04_FTMSms2hcd	65.500	282	306	49.1	2.2e-13	2.2e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	731.9075	2	-0.63	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-04_FTMSms2hcd	60.273	106	120	33.1	2.6e-13	6.0e-16	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	731.3617	3	0.60	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-04_FTMSms2hcd	51.139	234	253	36.6	3.8e-13	4.0e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	726.0297	3	0.11	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGMDVAASEFFR		20	V20130429-04_FTMSms2hcd	64.363	234	253	45.3	5.6e-13	5.7e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	915.1306	3	-0.45	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-04_FTMSms2hcd	58.443	203	228	44.8	6.6e-13	8.4e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	970.4935	2	1.5	LAMQEFMILPVGAANFR	LAM(Oxidation)QEFM(Oxidation)ILPVGAANFR	Oxidation@165;Oxidation@169	17	V20130429-04_FTMSms2hcd	56.649	163	179	44.8	7.0e-13	8.6e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	1148.5726	2	0.095	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-04_FTMSms2hcd	77.847	373	394	34.5	1.8e-12	2.2e-15	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	753.6486	4	0.94	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-04_FTMSms2hcd	58.552	133	162	39.0	6.6e-12	1.3e-14	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	634.3268	4	0.34	AAVPSGASTGIYEALELRDNDKTR	AAVPSGASTGIYEALELRDNDKTR		24	V20130429-04_FTMSms2hcd	43.426	33	56	44.0	2.0e-11	2.7e-14	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	703.8621	2	0.52	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-04_FTMSms2hcd	44.502	16	28	30.5	6.5e-10	8.8e-13	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	713.3678	2	1.6	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-04_FTMSms2hcd	48.804	270	281	34.1	1.7e-7	2.3e-10	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	450.2827	2	2.3	TIAPALVSK	TIAPALVSK		9	V20130429-04_FTMSms2hcd	26.583	72	80	27.8	2.4e-7	9.0e-10	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	572.3113	2	-0.32	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-04_FTMSms2hcd	22.928	184	193	36.8	3.5e-5	5.7e-8	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	14	52.8	7.55	2.2e-13	403.7299	2	0.76	YNQLLR	YNQLLR		6	V20130429-04_FTMSms2hcd	21.089	407	412	23.8	0.013	2.8e-5	1	47169.4	HUMAN	Alpha-enolase
[3-1]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	6.97	2.6e-13	731.9075	2	-0.63	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-04_FTMSms2hcd	60.273	106	120	33.1	2.6e-13	6.0e-16	3	47269.0	HUMAN	Gamma-enolase
[3-1]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	6.97	2.6e-13	1148.5726	2	0.095	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-04_FTMSms2hcd	77.847	373	394	34.5	1.8e-12	2.2e-15	3	47269.0	HUMAN	Gamma-enolase
[3-2]	0	P13929	ENOB_HUMAN	ENO3	2	8.5	6.97	2.6e-13	731.9075	2	-0.63	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-04_FTMSms2hcd	60.273	106	120	33.1	2.6e-13	6.0e-16	3	46932.2	HUMAN	Beta-enolase
[3-2]	0	P13929	ENOB_HUMAN	ENO3	2	8.5	6.97	2.6e-13	1148.5726	2	0.095	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-04_FTMSms2hcd	77.847	373	394	34.5	1.8e-12	2.2e-15	3	46932.2	HUMAN	Beta-enolase
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	755.1549	4	1.2	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-04_FTMSms2hcd	56.504	93	120	53.1	2.4e-15	6.0e-18	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	1088.0662	2	3.3	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-04_FTMSms2hcd	55.373	401	422	52.5	1.4e-14	1.9e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	668.6682	3	0.26	FGVEQDVDMVFASFIRK	FGVEQDVDM(Oxidation)VFASFIRK	Oxidation@239	17	V20130429-04_FTMSms2hcd	67.913	231	247	35.7	3.4e-13	3.7e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	663.3369	3	0.77	FGVEQDVDMVFASFIRK	FGVEQDVDMVFASFIRK		17	V20130429-04_FTMSms2hcd	71.418	231	247	28.7	5.9e-13	7.1e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	644.6671	3	0.31	EAEAAIYHLQLFEELR	EAEAAIYHLQLFEELR		16	V20130429-04_FTMSms2hcd	58.362	384	399	36.9	1.6e-10	2.1e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	625.9712	3	2.4	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-04_FTMSms2hcd	73.708	231	246	24.3	1.9e-10	2.0e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	696.7003	3	-0.44	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-04_FTMSms2hcd	53.530	384	400	55.7	5.7e-10	9.0e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	890.4424	2	0.89	GADFLVTEVENGGSLGSK	GADFLVTEVENGGSLGSK		18	V20130429-04_FTMSms2hcd	49.326	189	206	39.7	7.2e-10	8.4e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	706.9307	5	-0.16	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-04_FTMSms2hcd	45.347	1	32	33.9	4.1e-9	4.2e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	722.3845	4	2.7	GFFKKGDVVIVLTGWRPGSGFTNTMR	GFFKKGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	26	V20130429-04_FTMSms2hcd	55.144	501	526	23.6	7.5e-8	1.7e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	599.3279	2	0.96	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-04_FTMSms2hcd	35.850	33	43	37.5	2.0e-7	4.7e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	12	33.7	8.62	2.4e-15	420.7690	2	0.67	APIIAVTR	APIIAVTR		8	V20130429-04_FTMSms2hcd	26.716	448	455	37.0	1.9e-6	1.8e-8	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	1044.0380	2	-3.9	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-04_FTMSms2hcd	58.267	104	122	39.1	5.7e-14	7.2e-17	5	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	933.4529	3	0.28	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-04_FTMSms2hcd	61.536	78	103	43.0	4.7e-13	4.6e-16	5	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	979.9905	2	-4.1	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-04_FTMSms2hcd	62.207	104	121	34.0	6.8e-11	8.4e-14	5	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	668.3530	2	0.77	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-04_FTMSms2hcd	36.139	163	174	38.4	7.9e-11	1.3e-13	4	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	830.4520	2	0.91	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-04_FTMSms2hcd	56.904	283	297	44.0	8.6e-11	1.7e-13	1	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	943.4963	2	6.6	MAVTFIGNSTAIQELFK	M(Oxidation)AVTFIGNSTAIQELFK	Oxidation@363	17	V20130429-04_FTMSms2hcd	63.841	363	379	26.7	3.1e-8	4.8e-11	1	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	520.3013	2	1.8	YLTVAAVFR	YLTVAAVFR		9	V20130429-04_FTMSms2hcd	48.315	310	318	36.0	3.6e-8	1.4e-10	3	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	913.1789	4	-0.92	MSMKEVDEQMLNVQNKNSSYFVEWIPNNVK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNKNSSYFVEWIPNNVK	Oxidation@321;Oxidation@323;Oxidation@330	30	V20130429-04_FTMSms2hcd	50.139	321	350	19.4	2.4e-7	2.4e-10	4	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	49671.3	HUMAN	Tubulin beta chain
[5]		P07437	TBB5_HUMAN	TUBB	13	44.1	7.87	5.7e-14	782.2018	5	-1.1	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-04_FTMSms2hcd	69.057	217	252	17.4	9.7e-5	1.9e-7	5	49671.3	HUMAN	Tubulin beta chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	1044.0380	2	-3.9	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-04_FTMSms2hcd	58.267	104	122	39.1	5.7e-14	7.2e-17	5	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	933.4529	3	0.28	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-04_FTMSms2hcd	61.536	78	103	43.0	4.7e-13	4.6e-16	5	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	979.9905	2	-4.1	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-04_FTMSms2hcd	62.207	104	121	34.0	6.8e-11	8.4e-14	5	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	668.3530	2	0.77	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-04_FTMSms2hcd	36.139	163	174	38.4	7.9e-11	1.3e-13	4	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	520.3013	2	1.8	YLTVAAVFR	YLTVAAVFR		9	V20130429-04_FTMSms2hcd	48.315	310	318	36.0	3.6e-8	1.4e-10	3	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	913.1789	4	-0.92	MSMKEVDEQMLNVQNKNSSYFVEWIPNNVK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNKNSSYFVEWIPNNVK	Oxidation@321;Oxidation@323;Oxidation@330	30	V20130429-04_FTMSms2hcd	50.139	321	350	19.4	2.4e-7	2.4e-10	4	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[5-1]	0	P68371	TBB4B_HUMAN	TUBB4B	11	36.9	7.87	5.7e-14	782.2018	5	-1.1	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-04_FTMSms2hcd	69.057	217	252	17.4	9.7e-5	1.9e-7	5	49831.5	HUMAN	Tubulin beta-4B chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	1044.0380	2	-3.9	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-04_FTMSms2hcd	58.267	104	122	39.1	5.7e-14	7.2e-17	5	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	933.4529	3	0.28	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-04_FTMSms2hcd	61.536	78	103	43.0	4.7e-13	4.6e-16	5	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	979.9905	2	-4.1	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-04_FTMSms2hcd	62.207	104	121	34.0	6.8e-11	8.4e-14	5	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	913.1789	4	-0.92	MSMKEVDEQMLNVQNKNSSYFVEWIPNNVK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNKNSSYFVEWIPNNVK	Oxidation@321;Oxidation@323;Oxidation@330	30	V20130429-04_FTMSms2hcd	50.139	321	350	19.4	2.4e-7	2.4e-10	4	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[5-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	9	32.1	7.87	5.7e-14	782.2018	5	-1.1	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-04_FTMSms2hcd	69.057	217	252	17.4	9.7e-5	1.9e-7	5	49907.4	HUMAN	Tubulin beta-2A chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	1044.0380	2	-3.9	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-04_FTMSms2hcd	58.267	104	122	39.1	5.7e-14	7.2e-17	5	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	933.4529	3	0.28	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-04_FTMSms2hcd	61.536	78	103	43.0	4.7e-13	4.6e-16	5	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	979.9905	2	-4.1	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-04_FTMSms2hcd	62.207	104	121	34.0	6.8e-11	8.4e-14	5	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	913.1789	4	-0.92	MSMKEVDEQMLNVQNKNSSYFVEWIPNNVK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNKNSSYFVEWIPNNVK	Oxidation@321;Oxidation@323;Oxidation@330	30	V20130429-04_FTMSms2hcd	50.139	321	350	19.4	2.4e-7	2.4e-10	4	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[5-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	9	32.1	7.87	5.7e-14	782.2018	5	-1.1	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-04_FTMSms2hcd	69.057	217	252	17.4	9.7e-5	1.9e-7	5	49953.5	HUMAN	Tubulin beta-2B chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	933.4529	3	0.28	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-04_FTMSms2hcd	61.536	78	103	43.0	4.7e-13	4.6e-16	5	49586.2	HUMAN	Tubulin beta-4A chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49586.2	HUMAN	Tubulin beta-4A chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	668.3530	2	0.77	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-04_FTMSms2hcd	36.139	163	174	38.4	7.9e-11	1.3e-13	4	49586.2	HUMAN	Tubulin beta-4A chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	49586.2	HUMAN	Tubulin beta-4A chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49586.2	HUMAN	Tubulin beta-4A chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	520.3013	2	1.8	YLTVAAVFR	YLTVAAVFR		9	V20130429-04_FTMSms2hcd	48.315	310	318	36.0	3.6e-8	1.4e-10	3	49586.2	HUMAN	Tubulin beta-4A chain
[5-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	27.3	7.38	4.7e-13	782.2018	5	-1.1	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-04_FTMSms2hcd	69.057	217	252	17.4	9.7e-5	1.9e-7	5	49586.2	HUMAN	Tubulin beta-4A chain
[5-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	12.2	7.78	5.7e-14	1044.0380	2	-3.9	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-04_FTMSms2hcd	58.267	104	122	39.1	5.7e-14	7.2e-17	5	50433.2	HUMAN	Tubulin beta-3 chain
[5-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	12.2	7.78	5.7e-14	979.9905	2	-4.1	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-04_FTMSms2hcd	62.207	104	121	34.0	6.8e-11	8.4e-14	5	50433.2	HUMAN	Tubulin beta-3 chain
[5-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	12.2	7.78	5.7e-14	668.3530	2	0.77	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-04_FTMSms2hcd	36.139	163	174	38.4	7.9e-11	1.3e-13	4	50433.2	HUMAN	Tubulin beta-3 chain
[5-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	12.2	7.78	5.7e-14	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	50433.2	HUMAN	Tubulin beta-3 chain
[5-5]	0	Q13509	TBB3_HUMAN	TUBB3	5	12.2	7.78	5.7e-14	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	50433.2	HUMAN	Tubulin beta-3 chain
[5-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	3	8.5	6.59	1.3e-11	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49857.6	HUMAN	Tubulin beta-6 chain
[5-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	3	8.5	6.59	1.3e-11	848.9215	2	1.6	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-04_FTMSms2hcd	54.179	337	350	29.5	3.2e-10	3.6e-13	7	49857.6	HUMAN	Tubulin beta-6 chain
[5-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	3	8.5	6.59	1.3e-11	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49857.6	HUMAN	Tubulin beta-6 chain
[5-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	3	7.2	6.59	1.3e-11	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49776.5	HUMAN	Tubulin beta-8 chain
[5-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	3	7.2	6.59	1.3e-11	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49776.5	HUMAN	Tubulin beta-8 chain
[5-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	3	7.2	6.59	1.3e-11	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[5-8]	0	A6NKZ8	YI016_HUMAN		3	8.6	6.59	1.3e-11	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-04_FTMSms2hcd	51.755	191	204	41.6	1.3e-11	1.7e-14	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[5-8]	0	A6NKZ8	YI016_HUMAN		3	8.6	6.59	1.3e-11	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@185	10	V20130429-04_FTMSms2hcd	40.972	181	190	38.1	8.1e-10	1.2e-12	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[5-8]	0	A6NKZ8	YI016_HUMAN		3	8.6	6.59	1.3e-11	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	83	90	29.7	1.6e-6	2.6e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[5-9]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	6.59	1.3e-11	818.9197	2	1.0	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-04_FTMSms2hcd	51.755	263	276	41.6	1.3e-11	1.7e-14	9	49573.1	HUMAN	Tubulin beta-8 chain B
[5-9]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	6.59	1.3e-11	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	49573.1	HUMAN	Tubulin beta-8 chain B
[5-9]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	6.59	1.3e-11	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[5-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	2	4.0	5.44	8.1e-10	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-04_FTMSms2hcd	40.972	253	262	38.1	8.1e-10	1.2e-12	11	50327.4	HUMAN	Tubulin beta-1 chain
[5-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	2	4.0	5.44	8.1e-10	359.8492	3	0.65	IREEYPDR	IREEYPDR		8	V20130429-04_FTMSms2hcd	12.213	155	162	29.7	1.6e-6	2.6e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	794.9465	2	3.2	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-04_FTMSms2hcd	81.301	6	20	35.9	4.7e-17	1.1e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	897.4929	3	0.64	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-04_FTMSms2hcd	37.912	6	30	51.6	7.3e-16	3.0e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	813.9056	2	-0.26	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-04_FTMSms2hcd	21.434	38	51	53.9	5.2e-15	6.0e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	844.4665	3	2.4	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-04_FTMSms2hcd	51.325	267	290	42.0	8.9e-12	3.6e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	839.1332	3	0.41	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-04_FTMSms2hcd	55.704	267	290	27.8	4.9e-10	2.4e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	560.8037	2	0.38	STTTGHLIYK	STTTGHLIYK		10	V20130429-04_FTMSms2hcd	17.825	21	30	36.2	7.0e-9	1.2e-11	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	810.6429	5	2.8	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-04_FTMSms2hcd	70.210	219	255	29.7	3.6e-8	2.2e-10	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-04_FTMSms2hcd	31.174	256	266	46.2	9.0e-7	6.7e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	956.8177	3	9.3	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-04_FTMSms2hcd	77.265	101	129	19.1	4.5e-6	6.1e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	576.9846	3	-1.5	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-04_FTMSms2hcd	42.280	167	180	14.1	5.0e-6	1.2e-8	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[6]		P68104	EF1A1_HUMAN	EEF1A1	11	35.3	9.54	4.7e-17	457.7868	2	-0.68	QTVAVGVIK	QTVAVGVIK		9	V20130429-04_FTMSms2hcd	26.427	431	439	27.9	5.2e-6	1.5e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	794.9465	2	3.2	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-04_FTMSms2hcd	81.301	6	20	35.9	4.7e-17	1.1e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	897.4929	3	0.64	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-04_FTMSms2hcd	37.912	6	30	51.6	7.3e-16	3.0e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	813.9056	2	-0.26	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-04_FTMSms2hcd	21.434	38	51	53.9	5.2e-15	6.0e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	844.4665	3	2.4	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-04_FTMSms2hcd	51.325	267	290	42.0	8.9e-12	3.6e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	839.1332	3	0.41	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-04_FTMSms2hcd	55.704	267	290	27.8	4.9e-10	2.4e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	560.8037	2	0.38	STTTGHLIYK	STTTGHLIYK		10	V20130429-04_FTMSms2hcd	17.825	21	30	36.2	7.0e-9	1.2e-11	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	810.6429	5	2.8	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-04_FTMSms2hcd	70.210	219	255	29.7	3.6e-8	2.2e-10	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-04_FTMSms2hcd	31.174	256	266	46.2	9.0e-7	6.7e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	956.8177	3	9.3	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-04_FTMSms2hcd	77.265	101	129	19.1	4.5e-6	6.1e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	576.9846	3	-1.5	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-04_FTMSms2hcd	42.280	167	180	14.1	5.0e-6	1.2e-8	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	35.3	9.54	4.7e-17	457.7868	2	-0.68	QTVAVGVIK	QTVAVGVIK		9	V20130429-04_FTMSms2hcd	26.427	431	439	27.9	5.2e-6	1.5e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	794.9465	2	3.2	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-04_FTMSms2hcd	81.301	6	20	35.9	4.7e-17	1.1e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	897.4929	3	0.64	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-04_FTMSms2hcd	37.912	6	30	51.6	7.3e-16	3.0e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	813.9056	2	-0.26	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-04_FTMSms2hcd	21.434	38	51	53.9	5.2e-15	6.0e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	560.8037	2	0.38	STTTGHLIYK	STTTGHLIYK		10	V20130429-04_FTMSms2hcd	17.825	21	30	36.2	7.0e-9	1.2e-11	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-04_FTMSms2hcd	31.174	256	266	46.2	9.0e-7	6.7e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	956.8177	3	9.3	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-04_FTMSms2hcd	77.265	101	129	19.1	4.5e-6	6.1e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[6-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	19.0	9.54	4.7e-17	457.7868	2	-0.68	QTVAVGVIK	QTVAVGVIK		9	V20130429-04_FTMSms2hcd	26.427	431	439	27.9	5.2e-6	1.5e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	973.3983	2	-0.87	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=65	17	V20130429-04_FTMSms2hcd	12.158	250	266	50.8	7.0e-17	1.1e-19	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	594.9882	3	0.19	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-04_FTMSms2hcd	38.235	625	639	46.2	4.4e-15	7.7e-18	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	683.3698	2	2.1	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-04_FTMSms2hcd	39.413	83	95	49.6	4.1e-14	7.1e-17	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	571.2833	2	-0.27	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-04_FTMSms2hcd	12.954	439	448	42.4	1.3e-11	2.2e-14	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	757.3968	2	0.44	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-04_FTMSms2hcd	44.516	379	392	41.5	2.3e-10	3.5e-13	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	478.5170	4	0.78	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-04_FTMSms2hcd	33.494	624	639	19.9	1.3e-7	3.9e-10	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	603.6569	3	-1.1	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-04_FTMSms2hcd	56.317	205	219	14.4	2.0e-6	3.1e-9	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	576.2827	2	0.20	YIDQEELNK	YIDQEELNK		9	V20130429-04_FTMSms2hcd	20.670	276	284	23.2	3.8e-6	5.6e-9	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7]		P08238	HS90B_HUMAN	HSP90AB1	9	14.6	9.44	7.0e-17	863.8075	3	-3.4	TLTLVDTGIGMTKADLINNLGTIAK	TLTLVDTGIGM(Oxidation)TKADLINNLGTIAK	Oxidation@93	25	V20130429-04_FTMSms2hcd	59.568	83	107	15.2	8.6e-4	3.1e-6	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	6.6	7.95	4.1e-14	683.3698	2	2.1	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-04_FTMSms2hcd	39.413	88	100	49.6	4.1e-14	7.1e-17	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	6.6	7.95	4.1e-14	757.3968	2	0.44	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-04_FTMSms2hcd	44.516	387	400	41.5	2.3e-10	3.5e-13	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	6.6	7.95	4.1e-14	576.2827	2	0.20	YIDQEELNK	YIDQEELNK		9	V20130429-04_FTMSms2hcd	20.670	284	292	23.2	3.8e-6	5.6e-9	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-1]	0	P07900	HS90A_HUMAN	HSP90AA1	4	6.6	7.95	4.1e-14	863.8075	3	-3.4	TLTIVDTGIGMTKADLINNLGTIAK	TLTIVDTGIGM(Oxidation)TKADLINNLGTIAK	Oxidation@98	25	V20130429-04_FTMSms2hcd	59.568	88	112	15.2	8.6e-4	3.1e-6	2	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[7-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	3	10.8	9.44	7.0e-17	973.3983	2	-0.87	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=65	17	V20130429-04_FTMSms2hcd	12.158	172	188	50.8	7.0e-17	1.1e-19	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[7-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	3	10.8	9.44	7.0e-17	603.6569	3	-1.1	HSQFLGYPITLYLEK	HSQFLGYPITLYLEK		15	V20130429-04_FTMSms2hcd	56.317	127	141	14.4	2.0e-6	3.1e-9	3	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[7-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	3	10.8	9.44	7.0e-17	576.2827	2	0.20	YIDQEELNK	YIDQEELNK		9	V20130429-04_FTMSms2hcd	20.670	198	206	23.2	3.8e-6	5.6e-9	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[7-3]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	7.95	4.1e-14	683.3698	2	2.1	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-04_FTMSms2hcd	39.413	28	40	49.6	4.1e-14	7.1e-17	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[7-4]	1	Q12931	TRAP1_HUMAN	TRAP1	2	5.1	5.92	2.3e-10	757.3968	2	0.44	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-04_FTMSms2hcd	44.516	389	402	41.5	2.3e-10	3.5e-13	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[7-4]	1	Q12931	TRAP1_HUMAN	TRAP1	2	5.1	5.92	2.3e-10	838.3881	3	4.8	YESSALPSGQLTSLSEYASRMR	YES(Phospho)SALPSGQLTSLSEYASRMR	Phospho@472|473|477	22	V20130429-04_FTMSms2hcd	54.355	470	491	10.7	0.050	4.7e-5	1	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[7-5]	0	Q14568	HS902_HUMAN	HSP90AA2	1	2.6	1.97	3.8e-6	576.2827	2	0.20	YIDQEELNK	YIDQEELNK		9	V20130429-04_FTMSms2hcd	20.670	283	291	23.2	3.8e-6	5.6e-9	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[7-6]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	1	2.5	1.24	2.0e-6	603.6569	3	-1.1	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-04_FTMSms2hcd	56.317	184	198	14.4	2.0e-6	3.1e-9	3	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	859.4649	5	20	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR		37	V20130429-04_FTMSms2hcd	58.457	237	273	32.9	1.1e-12	7.1e-15	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	785.4052	5	-4.5	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-04_FTMSms2hcd	57.543	237	270	36.0	4.9e-12	9.8e-15	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	785.9533	2	2.7	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-04_FTMSms2hcd	65.564	411	424	45.9	7.1e-11	2.7e-13	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	748.3964	2	-0.54	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-04_FTMSms2hcd	30.487	37	50	39.8	1.5e-10	2.4e-13	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	635.7891	2	7.0	LGDLYEEEMR	LGDLYEEEM(Oxidation)R	Oxidation@154	10	V20130429-04_FTMSms2hcd	26.453	146	155	23.1	1.5e-9	2.4e-12	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	589.6068	3	0.62	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-04_FTMSms2hcd	16.380	365	378	29.6	2.8e-9	3.2e-12	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	859.9149	4	-0.58	LQEEMLQREEAENTLQSFRQDVDNASLAR	LQEEM(Oxidation)LQREEAENTLQSFRQDVDNASLAR	Oxidation@193	29	V20130429-04_FTMSms2hcd	51.579	189	217	31.4	3.2e-9	3.4e-12	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	513.9754	3	0.76	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-04_FTMSms2hcd	45.547	130	143	46.5	1.6e-7	1.2e-9	1	53652.1	HUMAN	Vimentin
[8]		P08670	VIME_HUMAN	VIM	9	30.0	7.17	1.1e-12	457.7330	2	1.0	SYVTTSTR	SYVTTSTR		8	V20130429-04_FTMSms2hcd	11.486	29	36	32.6	5.5e-7	1.1e-9	1	53652.1	HUMAN	Vimentin
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	715.7155	3	1.2	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-04_FTMSms2hcd	70.342	38	58	49.7	2.4e-15	4.3e-18	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	760.8803	2	1.4	TLNDELEIIEGMK	TLNDELEIIEGM(Oxidation)K	Oxidation@217	13	V20130429-04_FTMSms2hcd	48.210	206	218	40.8	7.8e-14	9.6e-17	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	646.9868	3	-0.97	TLNDELEIIEGMKFDR	TLNDELEIIEGM(Oxidation)KFDR	Oxidation@217	16	V20130429-04_FTMSms2hcd	50.325	206	221	39.1	3.4e-12	3.5e-15	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	524.9720	3	-0.95	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-04_FTMSms2hcd	59.408	143	157	34.7	4.7e-11	2.0e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	672.8629	2	2.0	TVIIEQSWGSPK	TVIIEQSWGSPK		12	V20130429-04_FTMSms2hcd	36.725	61	72	37.0	8.4e-8	1.4e-10	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	641.6564	3	0.96	TLNDELEIIEGMKFDR	TLNDELEIIEGMKFDR		16	V20130429-04_FTMSms2hcd	58.039	206	221	20.8	1.5e-6	1.7e-9	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	1151.8032	4	8.9	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVAS(Phospho)LLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537=8	47	V20130429-04_FTMSms2hcd	77.439	527	573	14.8	1.1e-5	1.6e-8	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[9]		P10809	CH60_HUMAN	HSPD1	8	19.4	8.61	2.4e-15	1151.8082	4	13	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVASLLT(Phospho)TAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|541|547	47	V20130429-04_FTMSms2hcd	77.489	527	573	14.3	7.0e-5	1.1e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	741.9040	2	1.5	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-04_FTMSms2hcd	40.825	81	93	36.9	7.3e-13	1.7e-15	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	527.0318	4	1.3	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-04_FTMSms2hcd	63.065	61	78	31.1	1.5e-10	2.5e-13	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	663.8521	2	-0.33	TVTAMDVVYALK	TVTAM(Oxidation)DVVYALK	Oxidation@85	12	V20130429-04_FTMSms2hcd	44.395	81	92	33.4	2.7e-10	5.1e-13	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	494.6224	3	-1.4	DNIQGITKPAIRR	DNIQGITKPAIRR		13	V20130429-04_FTMSms2hcd	23.615	25	37	34.1	1.3e-8	6.3e-11	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	567.7745	2	-0.75	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-04_FTMSms2hcd	12.320	69	78	31.1	4.0e-8	6.2e-11	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	663.3818	2	2.1	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-04_FTMSms2hcd	27.317	25	36	46.6	9.1e-8	3.4e-10	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	495.2934	2	1.7	VFLENVIR	VFLENVIR		8	V20130429-04_FTMSms2hcd	43.738	61	68	31.6	2.1e-7	6.2e-10	1	11367.4	HUMAN	Histone H4
[10]		P62805	H4_HUMAN	HIST1H4A	8	52.4	7.27	7.3e-13	590.8161	2	3.5	ISGLIYEETR	ISGLIYEETR		10	V20130429-04_FTMSms2hcd	33.287	47	56	13.7	6.2e-4	9.6e-7	1	11367.4	HUMAN	Histone H4
[11]		P11142	HSP7C_HUMAN	HSPA8	6	13.3	8.54	3.4e-15	846.3679	2	1.7	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-04_FTMSms2hcd	22.807	221	236	57.0	3.4e-15	4.6e-18	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	13.3	8.54	3.4e-15	661.3364	3	-1.6	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-04_FTMSms2hcd	46.127	138	155	33.6	2.1e-13	2.6e-16	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	13.3	8.54	3.4e-15	744.3559	2	2.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-04_FTMSms2hcd	34.920	37	49	41.0	6.3e-13	7.9e-16	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	13.3	8.54	3.4e-15	614.8183	2	1.0	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	26	36	43.6	2.0e-10	3.0e-13	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	13.3	8.54	3.4e-15	600.3407	2	-0.12	DAGTIAGLNVLR	DAGTIAGLNVLR		12	V20130429-04_FTMSms2hcd	45.534	160	171	36.0	2.0e-8	4.4e-11	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11]		P11142	HSP7C_HUMAN	HSPA8	6	13.3	8.54	3.4e-15	607.9692	3	1.0	NQVAMNPTNTVFDAKR	NQVAM(Oxidation)NPTNTVFDAKR	Oxidation@61	16	V20130429-04_FTMSms2hcd	27.407	57	72	19.0	4.0e-7	4.6e-10	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[11-1]	0	P54652	HSP72_HUMAN	HSPA2	3	6.3	8.54	3.4e-15	846.3679	2	1.7	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-04_FTMSms2hcd	22.807	224	239	57.0	3.4e-15	4.6e-18	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[11-1]	0	P54652	HSP72_HUMAN	HSPA2	3	6.3	8.54	3.4e-15	744.3559	2	2.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-04_FTMSms2hcd	34.920	38	50	41.0	6.3e-13	7.9e-16	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[11-1]	0	P54652	HSP72_HUMAN	HSPA2	3	6.3	8.54	3.4e-15	614.8183	2	1.0	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	27	37	43.6	2.0e-10	3.0e-13	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[11-2]	2	P11021	GRP78_HUMAN	HSPA5	3	6.6	9.12	2.7e-16	1083.0016	2	1.8	IEIESFYEGEDFSETLTR	IEIESFYEGEDFSETLTR		18	V20130429-04_FTMSms2hcd	56.434	307	324	50.6	2.7e-16	2.6e-19	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[11-2]	2	P11021	GRP78_HUMAN	HSPA5	3	6.6	9.12	2.7e-16	614.8183	2	1.0	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	50	60	43.6	2.0e-10	3.0e-13	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[11-2]	2	P11021	GRP78_HUMAN	HSPA5	3	6.6	9.12	2.7e-16	776.9011	2	1.4	TFAPEEISAMVLTK	TFAPEEISAM(Oxidation)VLTK	Oxidation@148	14	V20130429-04_FTMSms2hcd	48.830	139	152	30.2	1.1e-9	1.5e-12	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[11-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	7.31	6.3e-13	744.3559	2	2.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-04_FTMSms2hcd	34.920	37	49	41.0	6.3e-13	7.9e-16	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[11-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	7.31	6.3e-13	614.8183	2	1.0	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	26	36	43.6	2.0e-10	3.0e-13	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[11-4]	0	P17066	HSP76_HUMAN	HSPA6	2	3.7	7.31	6.3e-13	744.3559	2	2.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-04_FTMSms2hcd	34.920	39	51	41.0	6.3e-13	7.9e-16	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[11-4]	0	P17066	HSP76_HUMAN	HSPA6	2	3.7	7.31	6.3e-13	614.8183	2	1.0	VEILANDQGNR	VEILANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	28	38	43.6	2.0e-10	3.0e-13	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[11-5]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	7.31	6.3e-13	744.3559	2	2.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-04_FTMSms2hcd	34.920	39	51	41.0	6.3e-13	7.9e-16	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[11-5]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	7.31	6.3e-13	614.8183	2	1.0	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	28	38	43.6	2.0e-10	3.0e-13	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[11-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	7.31	6.3e-13	744.3559	2	2.2	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-04_FTMSms2hcd	34.920	39	51	41.0	6.3e-13	7.9e-16	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[11-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	7.31	6.3e-13	614.8183	2	1.0	VEILANDQGNR	VEILANDQGNR		11	V20130429-04_FTMSms2hcd	20.605	28	38	43.6	2.0e-10	3.0e-13	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[12]		P68363	TBA1B_HUMAN	TUBA1B	6	20.0	8.78	1.2e-15	800.0627	3	-2.1	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-04_FTMSms2hcd	49.033	85	105	59.6	1.2e-15	1.2e-18	6	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	6	20.0	8.78	1.2e-15	1004.4516	2	1.4	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-04_FTMSms2hcd	51.177	41	60	46.4	2.6e-13	2.8e-16	5	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	6	20.0	8.78	1.2e-15	851.4572	2	0.79	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-04_FTMSms2hcd	57.348	65	79	48.0	5.2e-12	9.3e-15	3	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	6	20.0	8.78	1.2e-15	744.4424	2	-1.1	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-04_FTMSms2hcd	67.684	230	243	41.9	1.4e-9	7.7e-12	5	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	6	20.0	8.78	1.2e-15	625.0490	4	-0.028	TIGGGDDSFNTFFSETGAGKHVPR	TIGGGDDSFNTFFSETGAGKHVPR		24	V20130429-04_FTMSms2hcd	45.964	41	64	28.6	1.2e-8	1.2e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	6	20.0	8.78	1.2e-15	586.3246	3	-2.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-04_FTMSms2hcd	52.371	265	280	17.8	7.0e-7	1.7e-9	6	50152.1	HUMAN	Tubulin alpha-1B chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	20.0	8.78	1.2e-15	800.0627	3	-2.1	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-04_FTMSms2hcd	49.033	85	105	59.6	1.2e-15	1.2e-18	6	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	20.0	8.78	1.2e-15	1004.4516	2	1.4	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-04_FTMSms2hcd	51.177	41	60	46.4	2.6e-13	2.8e-16	5	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	20.0	8.78	1.2e-15	851.4572	2	0.79	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-04_FTMSms2hcd	57.348	65	79	48.0	5.2e-12	9.3e-15	3	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	20.0	8.78	1.2e-15	744.4424	2	-1.1	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-04_FTMSms2hcd	67.684	230	243	41.9	1.4e-9	7.7e-12	5	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	20.0	8.78	1.2e-15	625.0490	4	-0.028	TIGGGDDSFNTFFSETGAGKHVPR	TIGGGDDSFNTFFSETGAGKHVPR		24	V20130429-04_FTMSms2hcd	45.964	41	64	28.6	1.2e-8	1.2e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	6	20.0	8.78	1.2e-15	586.3246	3	-2.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-04_FTMSms2hcd	52.371	265	280	17.8	7.0e-7	1.7e-9	6	49895.8	HUMAN	Tubulin alpha-1C chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	16.9	8.78	1.2e-15	800.0627	3	-2.1	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-04_FTMSms2hcd	49.033	85	105	59.6	1.2e-15	1.2e-18	6	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	16.9	8.78	1.2e-15	1004.4516	2	1.4	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-04_FTMSms2hcd	51.177	41	60	46.4	2.6e-13	2.8e-16	5	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	16.9	8.78	1.2e-15	851.4572	2	0.79	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-04_FTMSms2hcd	57.348	65	79	48.0	5.2e-12	9.3e-15	3	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	16.9	8.78	1.2e-15	625.0490	4	-0.028	TIGGGDDSFNTFFSETGAGKHVPR	TIGGGDDSFNTFFSETGAGKHVPR		24	V20130429-04_FTMSms2hcd	45.964	41	64	28.6	1.2e-8	1.2e-11	5	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	16.9	8.78	1.2e-15	586.3246	3	-2.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-04_FTMSms2hcd	52.371	265	280	17.8	7.0e-7	1.7e-9	6	50136.1	HUMAN	Tubulin alpha-1A chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	13.6	8.78	1.2e-15	800.0627	3	-2.1	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-04_FTMSms2hcd	49.033	85	105	59.6	1.2e-15	1.2e-18	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	13.6	8.78	1.2e-15	1004.4516	2	1.4	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-04_FTMSms2hcd	51.177	41	60	46.4	2.6e-13	2.8e-16	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	13.6	8.78	1.2e-15	625.0490	4	-0.028	TIGGGDDSFNTFFSETGAGKHVPR	TIGGGDDSFNTFFSETGAGKHVPR		24	V20130429-04_FTMSms2hcd	45.964	41	64	28.6	1.2e-8	1.2e-11	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	13.6	8.78	1.2e-15	586.3246	3	-2.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-04_FTMSms2hcd	52.371	265	280	17.8	7.0e-7	1.7e-9	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-4]	0	P68366	TBA4A_HUMAN	TUBA4A	3	11.4	8.78	1.2e-15	800.0627	3	-2.1	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-04_FTMSms2hcd	49.033	85	105	59.6	1.2e-15	1.2e-18	6	49924.9	HUMAN	Tubulin alpha-4A chain
[12-4]	0	P68366	TBA4A_HUMAN	TUBA4A	3	11.4	8.78	1.2e-15	744.4424	2	-1.1	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-04_FTMSms2hcd	67.684	230	243	41.9	1.4e-9	7.7e-12	5	49924.9	HUMAN	Tubulin alpha-4A chain
[12-4]	0	P68366	TBA4A_HUMAN	TUBA4A	3	11.4	8.78	1.2e-15	586.3246	3	-2.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-04_FTMSms2hcd	52.371	265	280	17.8	7.0e-7	1.7e-9	6	49924.9	HUMAN	Tubulin alpha-4A chain
[12-5]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	3	8.9	7.52	2.6e-13	1004.4516	2	1.4	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-04_FTMSms2hcd	51.177	41	60	46.4	2.6e-13	2.8e-16	5	49859.0	HUMAN	Tubulin alpha-3E chain
[12-5]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	3	8.9	7.52	2.6e-13	625.0490	4	-0.028	TIGGGDDSFNTFFSETGAGKHVPR	TIGGGDDSFNTFFSETGAGKHVPR		24	V20130429-04_FTMSms2hcd	45.964	41	64	28.6	1.2e-8	1.2e-11	5	49859.0	HUMAN	Tubulin alpha-3E chain
[12-5]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	3	8.9	7.52	2.6e-13	586.3246	3	-2.3	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-04_FTMSms2hcd	52.371	265	280	17.8	7.0e-7	1.7e-9	6	49859.0	HUMAN	Tubulin alpha-3E chain
[12-6]	0	Q9NY65	TBA8_HUMAN	TUBA8	2	7.8	8.78	1.2e-15	800.0627	3	-2.1	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-04_FTMSms2hcd	49.033	85	105	59.6	1.2e-15	1.2e-18	6	50094.0	HUMAN	Tubulin alpha-8 chain
[12-6]	0	Q9NY65	TBA8_HUMAN	TUBA8	2	7.8	8.78	1.2e-15	744.4424	2	-1.1	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-04_FTMSms2hcd	67.684	230	243	41.9	1.4e-9	7.7e-12	5	50094.0	HUMAN	Tubulin alpha-8 chain
[12-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.50	1.4e-9	744.4424	2	-1.1	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-04_FTMSms2hcd	67.684	169	182	41.9	1.4e-9	7.7e-12	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[13]		P62937	PPIA_HUMAN	PPIA	5	48.5	8.60	2.6e-15	917.4388	3	-0.24	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-04_FTMSms2hcd	48.129	92	118	54.8	2.6e-15	2.4e-18	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[13]		P62937	PPIA_HUMAN	PPIA	5	48.5	8.60	2.6e-15	611.3092	3	0.98	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-04_FTMSms2hcd	46.620	77	91	27.4	1.4e-11	1.6e-14	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[13]		P62937	PPIA_HUMAN	PPIA	5	48.5	8.60	2.6e-15	769.3729	2	2.4	VKEGMNIVEAMER	VKEGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	13	V20130429-04_FTMSms2hcd	18.033	132	144	40.0	2.7e-11	3.4e-14	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[13]		P62937	PPIA_HUMAN	PPIA	5	48.5	8.60	2.6e-15	758.4020	2	0.85	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-04_FTMSms2hcd	36.806	119	131	26.8	7.8e-7	1.3e-9	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[13]		P62937	PPIA_HUMAN	PPIA	5	48.5	8.60	2.6e-15	690.3848	2	3.9	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-04_FTMSms2hcd	47.527	20	31	27.9	1.8e-5	4.3e-8	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[14]		P09211	GSTP1_HUMAN	GSTP1	4	39.5	8.22	1.3e-14	1003.1627	3	0.60	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-04_FTMSms2hcd	57.586	20	45	46.5	1.3e-14	1.4e-17	1	23356.0	HUMAN	Glutathione S-transferase P
[14]		P09211	GSTP1_HUMAN	GSTP1	4	39.5	8.22	1.3e-14	955.8032	3	0.55	TLGLYGKDQQEAALVDMVNDGVEDLR	TLGLYGKDQQEAALVDM(Oxidation)VNDGVEDLR	Oxidation@92	26	V20130429-04_FTMSms2hcd	53.456	76	101	48.9	3.7e-13	3.7e-16	1	23356.0	HUMAN	Glutathione S-transferase P
[14]		P09211	GSTP1_HUMAN	GSTP1	4	39.5	8.22	1.3e-14	669.3663	2	0.066	MPPYTVVYFPVR	M(Met-loss)PPYTVVYFPVR	Met-loss@1	12	V20130429-04_FTMSms2hcd	49.446	1	12	44.1	4.2e-13	8.7e-16	1	23356.0	HUMAN	Glutathione S-transferase P
[14]		P09211	GSTP1_HUMAN	GSTP1	4	39.5	8.22	1.3e-14	1016.5313	2	2.7	AFLASPEYVNLPINGNGKQ	AFLASPEYVNLPINGNGKQ		19	V20130429-04_FTMSms2hcd	51.566	192	210	22.8	1.7e-9	2.5e-12	1	23356.0	HUMAN	Glutathione S-transferase P
[15]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	7.35	2.2e-13	675.3258	3	2.3	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-04_FTMSms2hcd	53.266	256	273	36.5	2.2e-13	2.3e-16	2	104854.9	HUMAN	Alpha-actinin-4
[15]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	7.35	2.2e-13	669.9921	3	-0.78	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-04_FTMSms2hcd	61.128	256	273	33.0	5.7e-12	6.0e-15	2	104854.9	HUMAN	Alpha-actinin-4
[15]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	7.35	2.2e-13	693.8907	2	0.11	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-04_FTMSms2hcd	65.806	734	745	36.7	2.5e-8	5.1e-11	2	104854.9	HUMAN	Alpha-actinin-4
[15]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	7.35	2.2e-13	715.3859	2	-0.0070	TINEVENQILTR	TINEVENQILTR		12	V20130429-04_FTMSms2hcd	38.805	746	757	38.0	4.1e-7	7.2e-10	2	104854.9	HUMAN	Alpha-actinin-4
[15]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	7.35	2.2e-13	685.0817	4	0.40	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@258	25	V20130429-04_FTMSms2hcd	51.458	256	280	18.9	1.5e-6	1.5e-9	2	104854.9	HUMAN	Alpha-actinin-4
[15-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	7.35	2.2e-13	675.3258	3	2.3	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-04_FTMSms2hcd	53.266	237	254	36.5	2.2e-13	2.3e-16	2	103058.4	HUMAN	Alpha-actinin-1
[15-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	7.35	2.2e-13	669.9921	3	-0.78	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-04_FTMSms2hcd	61.128	237	254	33.0	5.7e-12	6.0e-15	2	103058.4	HUMAN	Alpha-actinin-1
[15-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	7.35	2.2e-13	693.8907	2	0.11	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-04_FTMSms2hcd	65.806	715	726	36.7	2.5e-8	5.1e-11	2	103058.4	HUMAN	Alpha-actinin-1
[15-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	7.35	2.2e-13	715.3859	2	-0.0070	TINEVENQILTR	TINEVENQILTR		12	V20130429-04_FTMSms2hcd	38.805	727	738	38.0	4.1e-7	7.2e-10	2	103058.4	HUMAN	Alpha-actinin-1
[15-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	7.35	2.2e-13	685.0817	4	0.40	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@239	25	V20130429-04_FTMSms2hcd	51.458	237	261	18.9	1.5e-6	1.5e-9	2	103058.4	HUMAN	Alpha-actinin-1
[16]		P07355	ANXA2_HUMAN	ANXA2	4	16.8	6.77	6.3e-12	825.9941	2	1.2	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-04_FTMSms2hcd	69.876	89	104	54.8	6.3e-12	1.0e-13	2	38604.4	HUMAN	Annexin A2
[16]		P07355	ANXA2_HUMAN	ANXA2	4	16.8	6.77	6.3e-12	771.9285	2	0.73	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-04_FTMSms2hcd	59.636	50	63	54.7	6.7e-11	1.6e-13	1	38604.4	HUMAN	Annexin A2
[16]		P07355	ANXA2_HUMAN	ANXA2	4	16.8	6.77	6.3e-12	536.2796	2	1.5	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-04_FTMSms2hcd	34.150	1	10	37.1	2.6e-10	4.7e-13	2	38604.4	HUMAN	Annexin A2
[16]		P07355	ANXA2_HUMAN	ANXA2	4	16.8	6.77	6.3e-12	485.7458	4	0.33	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-04_FTMSms2hcd	40.731	153	169	34.0	3.5e-10	4.2e-13	2	38604.4	HUMAN	Annexin A2
[16-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.7	6.77	6.3e-12	825.9941	2	1.2	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-04_FTMSms2hcd	69.876	89	104	54.8	6.3e-12	1.0e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[16-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.7	6.77	6.3e-12	536.2796	2	1.5	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-04_FTMSms2hcd	34.150	1	10	37.1	2.6e-10	4.7e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[16-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.7	6.77	6.3e-12	485.7458	4	0.33	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-04_FTMSms2hcd	40.731	153	169	34.0	3.5e-10	4.2e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[17]		P06748	NPM_HUMAN	NPM1	4	22.8	9.38	9.0e-17	1122.1127	2	3.4	MSVQPTVSLGGFEITPPVVLR	M(Oxidation)SVQPTVSLGGFEITPPVVLR	Oxidation@81	21	V20130429-04_FTMSms2hcd	65.228	81	101	47.1	9.0e-17	2.6e-19	1	32575.3	HUMAN	Nucleophosmin
[17]		P06748	NPM_HUMAN	NPM1	4	22.8	9.38	9.0e-17	918.7360	4	0.58	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-04_FTMSms2hcd	62.650	46	80	43.9	1.7e-11	4.9e-14	1	32575.3	HUMAN	Nucleophosmin
[17]		P06748	NPM_HUMAN	NPM1	4	22.8	9.38	9.0e-17	737.1191	4	-0.51	TVSLGAGAKDELHIVEAEAMNYEGSPIK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIK	Oxidation@65	28	V20130429-04_FTMSms2hcd	53.718	46	73	21.4	1.0e-7	1.1e-10	1	32575.3	HUMAN	Nucleophosmin
[17]		P06748	NPM_HUMAN	NPM1	4	22.8	9.38	9.0e-17	565.8064	2	0.30	GPSSVEDIKAK	GPSSVEDIKAK		11	V20130429-04_FTMSms2hcd	14.927	240	250	31.3	5.1e-7	8.2e-10	1	32575.3	HUMAN	Nucleophosmin
[18]		P35579	MYH9_HUMAN	MYH9	5	3.7	6.93	3.1e-12	736.3889	3	4.8	TRLQQELDDLLVDLDHQR	TRLQQELDDLLVDLDHQR		18	V20130429-04_FTMSms2hcd	64.376	1416	1433	44.5	3.1e-12	5.0e-15	1	226534.2	HUMAN	Myosin-9
[18]		P35579	MYH9_HUMAN	MYH9	5	3.7	6.93	3.1e-12	539.0024	3	-0.92	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-04_FTMSms2hcd	58.081	342	356	23.9	1.7e-10	4.3e-12	1	226534.2	HUMAN	Myosin-9
[18]		P35579	MYH9_HUMAN	MYH9	5	3.7	6.93	3.1e-12	650.6677	3	-2.1	LQQELDDLLVDLDHQR	LQQELDDLLVDLDHQR		16	V20130429-04_FTMSms2hcd	58.146	1418	1433	22.6	4.9e-9	6.2e-12	1	226534.2	HUMAN	Myosin-9
[18]		P35579	MYH9_HUMAN	MYH9	5	3.7	6.93	3.1e-12	572.9150	3	0.11	TEMEDLMSSKDDVGK	TEM(Oxidation)EDLM(Oxidation)SSKDDVGK	Oxidation@1506;Oxidation@1510	15	V20130429-04_FTMSms2hcd	15.607	1504	1518	17.8	5.4e-5	7.7e-8	1	226534.2	HUMAN	Myosin-9
[18]		P35579	MYH9_HUMAN	MYH9	5	3.7	6.93	3.1e-12	795.0037	3	1.4	KGAGDGSDEEVDGKADGAEAKPAE	KGAGDGS(Phospho)DEEVDGKADGAEAKPAE	Phospho@1943	24	V20130429-04_FTMSms2hcd	15.728	1937	1960	16.4	1.0e-4	1.2e-7	1	226534.2	HUMAN	Myosin-9
[19]		P22626	ROA2_HUMAN	HNRNPA2B1	4	15.0	7.74	1.0e-13	956.4698	3	2.2	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-04_FTMSms2hcd	69.596	23	46	50.4	1.0e-13	1.1e-16	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[19]		P22626	ROA2_HUMAN	HNRNPA2B1	4	15.0	7.74	1.0e-13	899.9648	2	0.093	LFIGGLSFETTEESLR	LFIGGLSFETTEESLR		16	V20130429-04_FTMSms2hcd	59.194	23	38	43.5	1.7e-10	2.2e-13	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[19]		P22626	ROA2_HUMAN	HNRNPA2B1	4	15.0	7.74	1.0e-13	759.7241	3	1.2	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-04_FTMSms2hcd	55.614	154	173	32.9	7.3e-7	9.6e-10	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[19]		P22626	ROA2_HUMAN	HNRNPA2B1	4	15.0	7.74	1.0e-13	529.2975	2	-1.0	TLETVPLER	TLETVPLER		9	V20130429-04_FTMSms2hcd	30.300	4	12	24.4	2.5e-6	5.2e-9	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[20]		P31947	1433S_HUMAN	SFN	4	28.6	8.55	3.1e-15	844.9036	4	0.076	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-04_FTMSms2hcd	73.215	196	224	43.8	3.1e-15	3.1e-18	1	27774.3	HUMAN	14-3-3 protein sigma
[20]		P31947	1433S_HUMAN	SFN	4	28.6	8.55	3.1e-15	945.1656	3	1.8	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-04_FTMSms2hcd	70.329	170	195	47.2	6.8e-12	1.3e-14	1	27774.3	HUMAN	14-3-3 protein sigma
[20]		P31947	1433S_HUMAN	SFN	4	28.6	8.55	3.1e-15	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	42	49	26.6	4.6e-4	1.6e-6	7	27774.3	HUMAN	14-3-3 protein sigma
[20]		P31947	1433S_HUMAN	SFN	4	28.6	8.55	3.1e-15	452.2613	2	0.83	VLSSIEQK	VLSSIEQK		8	V20130429-04_FTMSms2hcd	15.166	61	68	22.4	5.6e-4	1.1e-6	5	27774.3	HUMAN	14-3-3 protein sigma
[20-1]	1	P63104	1433Z_HUMAN	YWHAZ	2	6.9	1.79	3.5e-5	581.7912	2	-1.8	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=8	9	V20130429-04_FTMSms2hcd	14.662	1	9	20.9	3.5e-5	5.1e-8	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[20-1]	1	P63104	1433Z_HUMAN	YWHAZ	2	6.9	1.79	3.5e-5	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	42	49	26.6	4.6e-4	1.6e-6	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[20-2]	0	P27348	1433T_HUMAN	YWHAQ	2	6.5	1.18	4.6e-4	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	42	49	26.6	4.6e-4	1.6e-6	7	27764.5	HUMAN	14-3-3 protein theta
[20-2]	0	P27348	1433T_HUMAN	YWHAQ	2	6.5	1.18	4.6e-4	452.2613	2	0.83	VISSIEQK	VISSIEQK		8	V20130429-04_FTMSms2hcd	15.166	61	68	22.4	5.6e-4	1.1e-6	5	27764.5	HUMAN	14-3-3 protein theta
[20-3]	0	P31946	1433B_HUMAN	YWHAB	2	6.5	1.18	4.6e-4	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	44	51	26.6	4.6e-4	1.6e-6	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[20-3]	0	P31946	1433B_HUMAN	YWHAB	2	6.5	1.18	4.6e-4	452.2613	2	0.83	VISSIEQK	VISSIEQK		8	V20130429-04_FTMSms2hcd	15.166	63	70	22.4	5.6e-4	1.1e-6	5	28082.6	HUMAN	14-3-3 protein beta/alpha
[20-4]	0	P61981	1433G_HUMAN	YWHAG	2	6.5	1.18	4.6e-4	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	43	50	26.6	4.6e-4	1.6e-6	7	28302.8	HUMAN	14-3-3 protein gamma
[20-4]	0	P61981	1433G_HUMAN	YWHAG	2	6.5	1.18	4.6e-4	452.2613	2	0.83	VISSIEQK	VISSIEQK		8	V20130429-04_FTMSms2hcd	15.166	62	69	22.4	5.6e-4	1.1e-6	5	28302.8	HUMAN	14-3-3 protein gamma
[20-5]	0	Q04917	1433F_HUMAN	YWHAH	2	6.5	1.18	4.6e-4	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	43	50	26.6	4.6e-4	1.6e-6	7	28219.0	HUMAN	14-3-3 protein eta
[20-5]	0	Q04917	1433F_HUMAN	YWHAH	2	6.5	1.18	4.6e-4	452.2613	2	0.83	VISSIEQK	VISSIEQK		8	V20130429-04_FTMSms2hcd	15.166	62	69	22.4	5.6e-4	1.1e-6	5	28219.0	HUMAN	14-3-3 protein eta
[20-6]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	1.18	4.6e-4	454.2663	2	0.64	NLLSVAYK	NLLSVAYK		8	V20130429-04_FTMSms2hcd	35.743	43	50	26.6	4.6e-4	1.6e-6	7	29174.2	HUMAN	14-3-3 protein epsilon
[21]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	6.92	3.3e-12	892.9580	2	1.2	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-04_FTMSms2hcd	58.215	16	31	44.5	3.3e-12	4.3e-15	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[21]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	6.92	3.3e-12	847.8536	2	-0.10	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-04_FTMSms2hcd	12.067	353	370	56.0	1.1e-11	1.6e-14	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[21]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	6.92	3.3e-12	591.4916	5	0.94	GFGFVTYATVEEVDAAMNARPHKVDGR	GFGFVTYATVEEVDAAM(Oxidation)NARPHKVDGR	Oxidation@72	27	V20130429-04_FTMSms2hcd	49.193	56	82	28.5	9.9e-9	9.9e-12	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[21]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	6.92	3.3e-12	761.0555	3	0.89	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-04_FTMSms2hcd	51.902	147	166	13.8	0.031	4.0e-5	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[21-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	6.92	3.3e-12	892.9580	2	1.2	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-04_FTMSms2hcd	58.215	16	31	44.5	3.3e-12	4.3e-15	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[21-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	6.92	3.3e-12	761.0555	3	0.89	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-04_FTMSms2hcd	51.902	147	166	13.8	0.031	4.0e-5	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[22]		P19338	NUCL_HUMAN	NCL	3	7.5	7.21	9.5e-13	640.3466	3	1.0	TGISDVFAKNDLAVVDVR	TGISDVFAKNDLAVVDVR		18	V20130429-04_FTMSms2hcd	52.452	325	342	35.0	9.5e-13	1.8e-15	1	76615.0	HUMAN	Nucleolin
[22]		P19338	NUCL_HUMAN	NCL	3	7.5	7.21	9.5e-13	834.4280	3	1.5	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-04_FTMSms2hcd	70.916	487	508	52.7	1.6e-12	2.2e-15	1	76615.0	HUMAN	Nucleolin
[22]		P19338	NUCL_HUMAN	NCL	3	7.5	7.21	9.5e-13	982.5190	4	4.0	TLVLSNLSYSATEETLQEVFEKATFIKVPQNQNGK	TLVLSNLSYSATEETLQEVFEKATFIKVPQNQNGK		35	V20130429-04_FTMSms2hcd	75.842	487	521	22.0	6.9e-10	2.1e-12	1	76615.0	HUMAN	Nucleolin
[23]		P23528	COF1_HUMAN	CFL1	4	40.4	7.08	1.7e-12	1021.5379	3	1.9	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-04_FTMSms2hcd	64.539	46	73	47.0	1.7e-12	3.6e-15	1	18502.7	HUMAN	Cofilin-1
[23]		P23528	COF1_HUMAN	CFL1	4	40.4	7.08	1.7e-12	947.9849	2	2.4	MASGVAVSDGVIKVFNDMK	M(Met-loss+Acetyl)ASGVAVSDGVIKVFNDM(Oxidation)K	Met-loss+Acetyl@1;Oxidation@18	19	V20130429-04_FTMSms2hcd	51.699	1	19	22.7	4.2e-9	5.2e-12	1	18502.7	HUMAN	Cofilin-1
[23]		P23528	COF1_HUMAN	CFL1	4	40.4	7.08	1.7e-12	572.8145	2	0.78	MASGVAVSDGVIK	M(Met-loss+Acetyl)ASGVAVSDGVIK	Met-loss+Acetyl@1	13	V20130429-04_FTMSms2hcd	35.649	1	13	29.9	3.2e-7	5.6e-10	1	18502.7	HUMAN	Cofilin-1
[23]		P23528	COF1_HUMAN	CFL1	4	40.4	7.08	1.7e-12	584.3152	4	0.41	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-04_FTMSms2hcd	61.562	93	112	21.2	1.7e-5	3.5e-8	2	18502.7	HUMAN	Cofilin-1
[23-1]	0	Q9Y281	COF2_HUMAN	CFL2	1	12.0	1.41	1.7e-5	584.3152	4	0.41	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-04_FTMSms2hcd	61.562	93	112	21.2	1.7e-5	3.5e-8	2	18736.8	HUMAN	Cofilin-2
[24]		P07737	PROF1_HUMAN	PFN1	3	18.6	8.06	2.6e-14	958.0392	2	3.3	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-04_FTMSms2hcd	54.636	39	56	46.8	2.6e-14	1.1e-16	1	15054.4	HUMAN	Profilin-1
[24]		P07737	PROF1_HUMAN	PFN1	3	18.6	8.06	2.6e-14	822.4766	2	5.6	TFVNITPAEVGVLVGK	TFVNITPAEVGVLVGK		16	V20130429-04_FTMSms2hcd	58.724	39	54	39.2	1.4e-11	6.3e-14	1	15054.4	HUMAN	Profilin-1
[24]		P07737	PROF1_HUMAN	PFN1	3	18.6	8.06	2.6e-14	445.7731	2	1.1	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-04_FTMSms2hcd	35.028	109	116	25.8	3.9e-8	2.4e-10	1	15054.4	HUMAN	Profilin-1
[25]		O60814	H2B1K_HUMAN	HIST1H2BK	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13890.3	HUMAN	Histone H2B type 1-K
[25]		O60814	H2B1K_HUMAN	HIST1H2BK	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13890.3	HUMAN	Histone H2B type 1-K
[25]		O60814	H2B1K_HUMAN	HIST1H2BK	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13890.3	HUMAN	Histone H2B type 1-K
[25-1]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13904.3	HUMAN	Histone H2B type 1-J
[25-1]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13904.3	HUMAN	Histone H2B type 1-J
[25-1]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13904.3	HUMAN	Histone H2B type 1-J
[25-2]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13906.3	HUMAN	Histone H2B type 1-O
[25-2]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13906.3	HUMAN	Histone H2B type 1-O
[25-2]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13906.3	HUMAN	Histone H2B type 1-O
[25-3]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13950.3	HUMAN	Histone H2B type 1-B
[25-3]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13950.3	HUMAN	Histone H2B type 1-B
[25-3]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13950.3	HUMAN	Histone H2B type 1-B
[25-4]	0	P57053	H2BFS_HUMAN	H2BFS	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13944.3	HUMAN	Histone H2B type F-S
[25-4]	0	P57053	H2BFS_HUMAN	H2BFS	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13944.3	HUMAN	Histone H2B type F-S
[25-4]	0	P57053	H2BFS_HUMAN	H2BFS	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13944.3	HUMAN	Histone H2B type F-S
[25-5]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13936.3	HUMAN	Histone H2B type 1-D
[25-5]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13936.3	HUMAN	Histone H2B type 1-D
[25-5]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13936.3	HUMAN	Histone H2B type 1-D
[25-6]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[25-6]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[25-6]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[25-7]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13920.3	HUMAN	Histone H2B type 2-E
[25-7]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13920.3	HUMAN	Histone H2B type 2-E
[25-7]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13920.3	HUMAN	Histone H2B type 2-E
[25-8]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13920.3	HUMAN	Histone H2B type 2-F
[25-8]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13920.3	HUMAN	Histone H2B type 2-F
[25-8]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13920.3	HUMAN	Histone H2B type 2-F
[25-9]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13908.2	HUMAN	Histone H2B type 3-B
[25-9]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13908.2	HUMAN	Histone H2B type 3-B
[25-9]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13908.2	HUMAN	Histone H2B type 3-B
[25-10]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13892.2	HUMAN	Histone H2B type 1-H
[25-10]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13892.2	HUMAN	Histone H2B type 1-H
[25-10]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13892.2	HUMAN	Histone H2B type 1-H
[25-11]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13922.3	HUMAN	Histone H2B type 1-N
[25-11]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13922.3	HUMAN	Histone H2B type 1-N
[25-11]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13922.3	HUMAN	Histone H2B type 1-N
[25-12]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13989.4	HUMAN	Histone H2B type 1-M
[25-12]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13989.4	HUMAN	Histone H2B type 1-M
[25-12]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13989.4	HUMAN	Histone H2B type 1-M
[25-13]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	20.6	7.44	3.6e-13	888.4089	2	0.79	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-04_FTMSms2hcd	55.011	59	73	51.0	3.6e-13	3.7e-16	14	13952.3	HUMAN	Histone H2B type 1-L
[25-13]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	20.6	7.44	3.6e-13	880.4069	2	-4.4	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=59	15	V20130429-04_FTMSms2hcd	64.470	59	73	44.2	2.3e-12	2.5e-15	14	13952.3	HUMAN	Histone H2B type 1-L
[25-13]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	20.6	7.44	3.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-04_FTMSms2hcd	18.718	48	58	35.6	2.3e-8	3.2e-11	15	13952.3	HUMAN	Histone H2B type 1-L
[25-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	1	8.7	4.40	2.3e-8	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@49	11	V20130429-04_FTMSms2hcd	18.718	49	59	35.6	2.3e-8	3.2e-11	15	14167.6	HUMAN	Histone H2B type 1-A
[26]		P31949	S10AB_HUMAN	S100A11	3	23.8	7.27	7.4e-13	925.4500	2	-6.1	TEFLSFMNTELAAFTK	TEFLSFMNTELAAFTK		16	V20130429-04_FTMSms2hcd	73.146	37	52	37.4	7.4e-13	7.6e-16	1	11740.6	HUMAN	Protein S100-A11
[26]		P31949	S10AB_HUMAN	S100A11	3	23.8	7.27	7.4e-13	933.4540	2	0.94	TEFLSFMNTELAAFTK	TEFLSFM(Oxidation)NTELAAFTK	Oxidation@43	16	V20130429-04_FTMSms2hcd	60.476	37	52	47.1	3.2e-11	3.5e-14	1	11740.6	HUMAN	Protein S100-A11
[26]		P31949	S10AB_HUMAN	S100A11	3	23.8	7.27	7.4e-13	510.2540	2	0.34	ISSPTETER	ISSPTETER		9	V20130429-04_FTMSms2hcd	12.385	4	12	29.5	6.2e-7	1.0e-9	1	11740.6	HUMAN	Protein S100-A11
[27]		P13639	EF2_HUMAN	EEF2	3	6.5	6.68	9.3e-12	849.7727	3	2.3	STAISLFYELSENDLNFIKQSK	STAISLFYELSENDLNFIKQSK		22	V20130429-04_FTMSms2hcd	72.745	72	93	30.2	9.3e-12	1.4e-14	1	95339.0	HUMAN	Elongation factor 2
[27]		P13639	EF2_HUMAN	EEF2	3	6.5	6.68	9.3e-12	785.0784	3	0.84	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-04_FTMSms2hcd	68.514	668	688	40.6	1.6e-10	2.5e-13	1	95339.0	HUMAN	Elongation factor 2
[27]		P13639	EF2_HUMAN	EEF2	3	6.5	6.68	9.3e-12	722.8903	2	3.5	EGIPALDNFLDKL	EGIPALDNFLDKL		13	V20130429-04_FTMSms2hcd	72.073	846	858	21.5	3.9e-7	6.6e-10	1	95339.0	HUMAN	Elongation factor 2
[28]		P02765	FETUA_HUMAN	AHSG	4	3.5	5.94	1.9e-11	640.7569	2	0.46	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-04_FTMSms2hcd	13.298	132	143	34.3	1.9e-11	4.7e-14	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[28]		P02765	FETUA_HUMAN	AHSG	4	3.5	5.94	1.9e-11	470.2053	3	0.32	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-04_FTMSms2hcd	9.958	132	144	26.4	1.2e-9	2.0e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[28]		P02765	FETUA_HUMAN	AHSG	4	3.5	5.94	1.9e-11	496.8601	3	-1.00	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=14	13	V20130429-04_FTMSms2hcd	11.189	132	144	19.9	2.7e-7	7.1e-10	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[28]		P02765	FETUA_HUMAN	AHSG	4	3.5	5.94	1.9e-11	784.7745	2	5.2	CDSSPDSAEDVRK	CDS(Phospho)SPDS(Phospho)AEDVRK	Phospho@138=8;Phospho@134|135	13	V20130429-04_FTMSms2hcd	12.398	132	144	15.6	1.8e-4	7.9e-7	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[29]		P62158	CALM_HUMAN	CALM1	2	45.6	9.73	2.1e-17	1130.5485	3	1.1	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-04_FTMSms2hcd	72.987	1	31	54.5	2.1e-17	2.3e-20	1	16837.7	HUMAN	Calmodulin
[29]		P62158	CALM_HUMAN	CALM1	2	45.6	9.73	2.1e-17	1030.2133	4	0.061	SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR	SLGQNPTEAELQDM(Oxidation)INEVDADGNGTIDFPEFLTM(Oxidation)M(Oxidation)AR	Oxidation@52;Oxidation@72;Oxidation@73	37	V20130429-04_FTMSms2hcd	67.939	39	75	37.9	2.4e-12	3.1e-15	1	16837.7	HUMAN	Calmodulin
[30]		Q15366	PCBP2_HUMAN	PCBP2	2	17.3	8.29	9.4e-15	846.6766	4	0.72	AFAMIIDKLEEDISSSMTNSTAASRPPVTLR	AFAM(Oxidation)IIDKLEEDISSSM(Oxidation)TNSTAASRPPVTLR	Oxidation@74;Oxidation@87	31	V20130429-04_FTMSms2hcd	63.290	71	101	45.5	9.4e-15	1.2e-17	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[30]		Q15366	PCBP2_HUMAN	PCBP2	2	17.3	8.29	9.4e-15	1115.6018	3	3.0	IANPVEGSTDRQVTITGSAASISLAQYLINVR	IANPVEGSTDRQVTITGSAASISLAQYLINVR		32	V20130429-04_FTMSms2hcd	64.577	323	354	57.0	2.4e-14	8.0e-17	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[31]		P04792	HSPB1_HUMAN	HSPB1	3	21.0	6.93	3.1e-12	953.5031	2	3.8	LATQSNEITIPVTFESR	LATQSNEITIPVTFESR		17	V20130429-04_FTMSms2hcd	48.710	172	188	51.1	3.1e-12	5.0e-15	1	22782.7	HUMAN	Heat shock protein beta-1
[31]		P04792	HSPB1_HUMAN	HSPB1	3	21.0	6.93	3.1e-12	892.4664	2	1.7	VSLDVNHFAPDELTVK	VSLDVNHFAPDELTVK		16	V20130429-04_FTMSms2hcd	46.995	97	112	36.5	2.7e-10	4.0e-13	1	22782.7	HUMAN	Heat shock protein beta-1
[31]		P04792	HSPB1_HUMAN	HSPB1	3	21.0	6.93	3.1e-12	582.3100	2	-6.9	LFDQAFGLPR	LFDQAFGLPR		10	V20130429-04_FTMSms2hcd	48.684	28	37	35.0	1.6e-5	2.5e-8	1	22782.7	HUMAN	Heat shock protein beta-1
[32]		P37802	TAGL2_HUMAN	TAGLN2	3	22.1	5.89	2.7e-10	1050.5199	2	2.0	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-04_FTMSms2hcd	69.234	103	120	42.8	2.7e-10	2.8e-13	1	22391.7	HUMAN	Transgelin-2
[32]		P37802	TAGL2_HUMAN	TAGLN2	3	22.1	5.89	2.7e-10	708.3054	2	-0.48	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-04_FTMSms2hcd	12.252	183	196	30.1	1.1e-7	2.0e-10	2	22391.7	HUMAN	Transgelin-2
[32]		P37802	TAGL2_HUMAN	TAGLN2	3	22.1	5.89	2.7e-10	602.3157	2	1.0	MANRGPAYGLSR	M(Met-loss+Acetyl)ANRGPAYGLSR	Met-loss+Acetyl@1	12	V20130429-04_FTMSms2hcd	22.794	1	12	38.1	3.3e-7	4.6e-10	1	22391.7	HUMAN	Transgelin-2
[32-1]	0	Q9UI15	TAGL3_HUMAN	TAGLN3	1	7.0	3.48	1.1e-7	708.3054	2	-0.48	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-04_FTMSms2hcd	12.252	183	196	30.1	1.1e-7	2.0e-10	2	22472.9	HUMAN	Transgelin-3
[33]		Q13268	DHRS2_HUMAN	DHRS2	2	10.1	7.91	4.8e-14	887.5107	3	1.6	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-04_FTMSms2hcd	68.644	142	167	42.9	4.8e-14	6.6e-16	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[33]		Q13268	DHRS2_HUMAN	DHRS2	2	10.1	7.91	4.8e-14	835.4786	3	3.6	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-04_FTMSms2hcd	74.139	143	167	25.6	5.7e-10	5.1e-12	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[34]		P00558	PGK1_HUMAN	PGK1	3	13.9	5.79	2.8e-10	1124.5852	3	-0.036	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-04_FTMSms2hcd	64.096	217	246	39.1	2.8e-10	5.5e-13	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[34]		P00558	PGK1_HUMAN	PGK1	3	13.9	5.79	2.8e-10	590.3373	3	0.99	ALESPERPFLAILGGAK	ALESPERPFLAILGGAK		17	V20130429-04_FTMSms2hcd	56.223	200	216	26.4	1.2e-6	4.8e-9	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[34]		P00558	PGK1_HUMAN	PGK1	3	13.9	5.79	2.8e-10	549.3137	2	0.020	VLPGVDALSNI	VLPGVDALSNI		11	V20130429-04_FTMSms2hcd	55.691	407	417	13.8	1.3e-5	4.2e-8	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[35]		Q08211	DHX9_HUMAN	DHX9	2	2.8	7.53	1.5e-13	1025.5143	2	-1.3	TTQVPQFILDDFIQNDR	TTQVPQFILDDFIQNDR		17	V20130429-04_FTMSms2hcd	64.389	418	434	38.9	1.5e-13	1.9e-16	1	140959.7	HUMAN	ATP-dependent RNA helicase A
[35]		Q08211	DHX9_HUMAN	DHX9	2	2.8	7.53	1.5e-13	693.0098	3	0.52	FSDHVALLSVFQAWDDAR	FSDHVALLSVFQAWDDAR		18	V20130429-04_FTMSms2hcd	67.603	912	929	31.2	5.0e-9	5.4e-12	1	140959.7	HUMAN	ATP-dependent RNA helicase A
[36]		P16403	H12_HUMAN	HIST1H1C	2	16.9	6.12	1.0e-10	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-04_FTMSms2hcd	21.182	65	79	63.8	1.0e-10	1.3e-13	5	21364.9	HUMAN	Histone H1.2
[36]		P16403	H12_HUMAN	HIST1H1C	2	16.9	6.12	1.0e-10	958.5126	2	2.9	MSETAPAAPAAAPPAEKAPVK	M(Met-loss+Acetyl)SETAPAAPAAAPPAEKAPVK	Met-loss+Acetyl@1	21	V20130429-04_FTMSms2hcd	26.505	1	21	27.1	1.8e-10	3.4e-13	1	21364.9	HUMAN	Histone H1.2
[36-1]	0	P10412	H14_HUMAN	HIST1H1E	1	6.8	6.12	1.0e-10	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-04_FTMSms2hcd	21.182	65	79	63.8	1.0e-10	1.3e-13	5	21865.4	HUMAN	Histone H1.4
[36-2]	0	P16402	H13_HUMAN	HIST1H1D	1	6.8	6.12	1.0e-10	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-04_FTMSms2hcd	21.182	66	80	63.8	1.0e-10	1.3e-13	5	22350.1	HUMAN	Histone H1.3
[36-3]	0	P22492	H1T_HUMAN	HIST1H1T	1	7.2	6.12	1.0e-10	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-04_FTMSms2hcd	21.182	69	83	63.8	1.0e-10	1.3e-13	5	22019.2	HUMAN	Histone H1t
[36-4]	0	Q02539	H11_HUMAN	HIST1H1A	1	7.0	6.12	1.0e-10	789.8981	2	1.2	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-04_FTMSms2hcd	21.182	68	82	63.8	1.0e-10	1.3e-13	5	21842.3	HUMAN	Histone H1.1
[37]		P25705	ATPA_HUMAN	ATP5A1	2	5.2	6.27	5.3e-11	812.9503	2	1.8	TGAIVDVPVGEELLGR	TGAIVDVPVGEELLGR		16	V20130429-04_FTMSms2hcd	54.114	134	149	47.7	5.3e-11	1.3e-13	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[37]		P25705	ATPA_HUMAN	ATP5A1	2	5.2	6.27	5.3e-11	720.3391	2	1.9	TGTAEMSSILEER	TGTAEM(Oxidation)SSILEER	Oxidation@51	13	V20130429-04_FTMSms2hcd	26.132	46	58	46.0	6.9e-10	8.4e-13	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[38]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14091.6	HUMAN	Histone H2A type 1
[38]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	14091.6	HUMAN	Histone H2A type 1
[38]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14091.6	HUMAN	Histone H2A type 1
[38]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14091.6	HUMAN	Histone H2A type 1
[38-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14107.6	HUMAN	Histone H2A type 1-D
[38-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[38-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14107.6	HUMAN	Histone H2A type 1-D
[38-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14107.6	HUMAN	Histone H2A type 1-D
[38-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	13988.5	HUMAN	Histone H2A type 2-C
[38-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[38-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	13988.5	HUMAN	Histone H2A type 2-C
[38-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	13988.5	HUMAN	Histone H2A type 2-C
[38-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14095.6	HUMAN	Histone H2A type 2-A
[38-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[38-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14095.6	HUMAN	Histone H2A type 2-A
[38-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14095.6	HUMAN	Histone H2A type 2-A
[38-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	13906.4	HUMAN	Histone H2A type 1-H
[38-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[38-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	13906.4	HUMAN	Histone H2A type 1-H
[38-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	13906.4	HUMAN	Histone H2A type 1-H
[38-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	13936.4	HUMAN	Histone H2A type 1-J
[38-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[38-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	13936.4	HUMAN	Histone H2A type 1-J
[38-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	13936.4	HUMAN	Histone H2A type 1-J
[38-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14019.5	HUMAN	Histone H2A.J
[38-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.39	6.1e-9	702.0679	3	0.87	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-04_FTMSms2hcd	45.928	83	100	28.6	5.3e-6	3.0e-8	7	14019.5	HUMAN	Histone H2A.J
[38-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14019.5	HUMAN	Histone H2A.J
[38-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14019.5	HUMAN	Histone H2A.J
[38-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14135.6	HUMAN	Histone H2A type 1-B/E
[38-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14135.6	HUMAN	Histone H2A type 1-B/E
[38-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14135.6	HUMAN	Histone H2A type 1-B/E
[38-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14121.6	HUMAN	Histone H2A type 3
[38-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14121.6	HUMAN	Histone H2A type 3
[38-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14121.6	HUMAN	Histone H2A type 3
[38-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.39	6.1e-9	644.3940	3	-0.71	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-04_FTMSms2hcd	65.444	101	119	28.6	6.1e-9	1.6e-10	10	14105.6	HUMAN	Histone H2A type 1-C
[38-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.39	6.1e-9	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14105.6	HUMAN	Histone H2A type 1-C
[38-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.39	6.1e-9	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14105.6	HUMAN	Histone H2A type 1-C
[38-10]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	2	12.5	2.73	7.5e-6	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	86	92	17.2	7.5e-6	7.3e-8	14	13552.8	HUMAN	Histone H2A.Z
[38-10]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	2	12.5	2.73	7.5e-6	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	24	32	32.4	2.4e-4	4.0e-7	15	13552.8	HUMAN	Histone H2A.Z
[38-11]	0	P16104	H2AX_HUMAN	H2AFX	2	11.2	2.73	7.5e-6	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	15144.7	HUMAN	Histone H2A.x
[38-11]	0	P16104	H2AX_HUMAN	H2AFX	2	11.2	2.73	7.5e-6	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	15144.7	HUMAN	Histone H2A.x
[38-12]	0	Q71UI9	H2AV_HUMAN	H2AFV	2	12.5	2.73	7.5e-6	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	86	92	17.2	7.5e-6	7.3e-8	14	13508.8	HUMAN	Histone H2A.V
[38-12]	0	Q71UI9	H2AV_HUMAN	H2AFV	2	12.5	2.73	7.5e-6	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	24	32	32.4	2.4e-4	4.0e-7	15	13508.8	HUMAN	Histone H2A.V
[38-13]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	12.2	2.73	7.5e-6	425.7663	2	-0.50	HLQLAIR	HLQLAIR		7	V20130429-04_FTMSms2hcd	26.039	83	89	17.2	7.5e-6	7.3e-8	14	14233.6	HUMAN	Histone H2A type 1-A
[38-13]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	12.2	2.73	7.5e-6	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	14233.6	HUMAN	Histone H2A type 1-A
[38-14]	0	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	1	6.9	1.91	2.4e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-04_FTMSms2hcd	36.543	22	30	32.4	2.4e-4	4.0e-7	15	13995.4	HUMAN	Histone H2A type 2-B
[39]		P62081	RS7_HUMAN	RPS7	2	11.9	5.99	1.7e-10	789.7660	3	1.2	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-04_FTMSms2hcd	68.632	121	142	28.2	1.7e-10	4.5e-13	1	22127.0	HUMAN	40S ribosomal protein S7
[39]		P62081	RS7_HUMAN	RPS7	2	11.9	5.99	1.7e-10	631.6005	4	-0.61	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-04_FTMSms2hcd	65.030	121	143	40.0	3.3e-10	1.4e-12	1	22127.0	HUMAN	40S ribosomal protein S7
[40]		P61978	HNRPK_HUMAN	HNRNPK	2	6.7	6.70	5.3e-12	615.0322	3	1.8	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-04_FTMSms2hcd	71.216	87	103	37.9	5.3e-12	7.4e-14	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[40]		P61978	HNRPK_HUMAN	HNRNPK	2	6.7	6.70	5.3e-12	518.6471	3	0.40	IILDLISESPIKGR	IILDLISESPIKGR		14	V20130429-04_FTMSms2hcd	51.915	208	221	38.9	5.8e-8	4.8e-10	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[41]		P20700	LMNB1_HUMAN	LMNB1	2	6.8	9.35	1.0e-16	1137.8639	3	1.8	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-04_FTMSms2hcd	61.204	548	577	53.3	1.0e-16	1.0e-19	1	66408.9	HUMAN	Lamin-B1
[41]		P20700	LMNB1_HUMAN	LMNB1	2	6.8	9.35	1.0e-16	455.2610	2	-0.57	MATATPVPPR	M(Met-loss)ATATPVPPR	Met-loss@1	10	V20130429-04_FTMSms2hcd	9.186	1	10	11.8	0.050	1.3e-4	1	66408.9	HUMAN	Lamin-B1
[42]		P60174	TPIS_HUMAN	TPI1	2	8.7	5.72	6.8e-11	801.9479	2	-0.30	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-04_FTMSms2hcd	55.822	198	212	35.1	6.8e-11	1.7e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[42]		P60174	TPIS_HUMAN	TPI1	2	8.7	5.72	6.8e-11	540.7786	2	-0.66	IAVAAQNCYK	IAVAAQNCYK		10	V20130429-04_FTMSms2hcd	22.142	97	106	23.7	1.3e-8	1.8e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[43]		P78371	TCPB_HUMAN	CCT2	3	9.3	3.82	2.2e-8	759.4513	2	1.0	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-04_FTMSms2hcd	67.672	26	40	29.7	2.2e-8	1.7e-10	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[43]		P78371	TCPB_HUMAN	CCT2	3	9.3	3.82	2.2e-8	651.3760	2	-1.3	MASLSLAPVNIFK	M(Met-loss+Acetyl)ASLSLAPVNIFK	Met-loss+Acetyl@1	13	V20130429-04_FTMSms2hcd	65.793	1	13	25.1	9.5e-8	2.6e-10	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[43]		P78371	TCPB_HUMAN	CCT2	3	9.3	3.82	2.2e-8	763.3926	3	0.71	VQDDEVGDGTTSVTVLAAELLR	VQDDEVGDGTTSVTVLAAELLR		22	V20130429-04_FTMSms2hcd	68.552	90	111	22.8	1.1e-6	1.4e-9	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[44]		Q01518	CAP1_HUMAN	CAP1	2	4.6	5.14	2.8e-10	758.1035	3	7.1	LGLVFDDVVGIVEIINSKDVK	LGLVFDDVVGIVEIINSKDVK		21	V20130429-04_FTMSms2hcd	77.359	378	398	32.1	2.8e-10	2.1e-12	1	51901.9	HUMAN	Adenylyl cyclase-associated protein 1
[44]		Q01518	CAP1_HUMAN	CAP1	2	4.6	5.14	2.8e-10	800.7938	3	-3.3	KLGLVFDDVVGIVEIINSKDVK	KLGLVFDDVVGIVEIINSKDVK		22	V20130429-04_FTMSms2hcd	76.096	377	398	32.6	4.4e-10	3.9e-12	1	51901.9	HUMAN	Adenylyl cyclase-associated protein 1
[45]		P06753	TPM3_HUMAN	TPM3	2	9.5	5.61	8.8e-10	492.8981	3	-1.0	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-04_FTMSms2hcd	13.399	113	125	43.5	8.8e-10	1.0e-12	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[45]		P06753	TPM3_HUMAN	TPM3	2	9.5	5.61	8.8e-10	864.4523	2	2.9	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-04_FTMSms2hcd	38.020	92	105	28.6	1.6e-7	2.5e-10	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[45-1]	0	P07951	TPM2_HUMAN	TPM2	2	9.5	5.61	8.8e-10	492.8981	3	-1.0	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-04_FTMSms2hcd	13.399	113	125	43.5	8.8e-10	1.0e-12	4	32851.0	HUMAN	Tropomyosin beta chain
[45-1]	0	P07951	TPM2_HUMAN	TPM2	2	9.5	5.61	8.8e-10	864.4523	2	2.9	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-04_FTMSms2hcd	38.020	92	105	28.6	1.6e-7	2.5e-10	4	32851.0	HUMAN	Tropomyosin beta chain
[45-2]	0	P09493	TPM1_HUMAN	TPM1	2	9.5	5.61	8.8e-10	492.8981	3	-1.0	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-04_FTMSms2hcd	13.399	113	125	43.5	8.8e-10	1.0e-12	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[45-2]	0	P09493	TPM1_HUMAN	TPM1	2	9.5	5.61	8.8e-10	864.4523	2	2.9	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-04_FTMSms2hcd	38.020	92	105	28.6	1.6e-7	2.5e-10	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[45-3]	0	P67936	TPM4_HUMAN	TPM4	2	10.9	5.61	8.8e-10	492.8981	3	-1.0	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-04_FTMSms2hcd	13.399	77	89	43.5	8.8e-10	1.0e-12	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[45-3]	0	P67936	TPM4_HUMAN	TPM4	2	10.9	5.61	8.8e-10	864.4523	2	2.9	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-04_FTMSms2hcd	38.020	56	69	28.6	1.6e-7	2.5e-10	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[46]		Q15365	PCBP1_HUMAN	PCBP1	1	5.9	9.23	1.7e-16	1089.1024	2	2.3	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-04_FTMSms2hcd	63.975	326	346	51.5	1.7e-16	5.8e-19	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[47]		P61604	CH10_HUMAN	HSPE1	2	20.6	5.86	7.6e-11	658.3829	2	0.40	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-04_FTMSms2hcd	30.079	41	54	36.8	7.6e-11	2.1e-13	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[47]		P61604	CH10_HUMAN	HSPE1	2	20.6	5.86	7.6e-11	454.2551	2	-0.76	FLPLFDR	FLPLFDR		7	V20130429-04_FTMSms2hcd	49.248	9	15	29.8	1.0e-4	2.4e-7	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[48]		P35232	PHB_HUMAN	PHB	2	19.5	5.01	9.0e-11	791.0905	3	2.2	FGLALAVAGGVVNSALYNVDAGHR	FGLALAVAGGVVNSALYNVDAGHR		24	V20130429-04_FTMSms2hcd	67.616	12	35	28.6	9.0e-11	1.9e-13	1	29804.3	HUMAN	Prohibitin
[48]		P35232	PHB_HUMAN	PHB	2	19.5	5.01	9.0e-11	1041.8789	3	-0.87	AATFGLILDDVSLTHLTFGKEFTEAVEAK	AATFGLILDDVSLTHLTFGKEFTEAVEAK		29	V20130429-04_FTMSms2hcd	73.346	158	186	22.0	9.6e-8	1.8e-10	1	29804.3	HUMAN	Prohibitin
[49]		P07195	LDHB_HUMAN	LDHB	2	9.3	4.08	5.9e-7	643.8701	2	1.2	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-04_FTMSms2hcd	17.490	309	319	40.0	5.9e-7	1.5e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[49]		P07195	LDHB_HUMAN	LDHB	2	9.3	4.08	5.9e-7	639.3615	3	-0.42	ITVVGVGQVGMACAISILGK	ITVVGVGQVGMACAISILGK		20	V20130429-04_FTMSms2hcd	76.260	24	43	25.9	7.5e-7	2.8e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[50]		P05091	ALDH2_HUMAN	ALDH2	1	2.7	8.03	2.2e-14	895.4191	2	1.7	TFVQEDIYDEFVER	TFVQEDIYDEFVER		14	V20130429-04_FTMSms2hcd	54.528	325	338	39.3	2.2e-14	2.4e-17	1	56381.8	HUMAN	Aldehyde dehydrogenase, mitochondrial
[51]		P52272	HNRPM_HUMAN	HNRNPM	1	4.5	7.77	8.7e-14	924.7192	4	-0.28	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-04_FTMSms2hcd	76.166	245	277	40.0	8.7e-14	1.3e-16	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[52]		Q16658	FSCN1_HUMAN	FSCN1	1	4.9	7.76	9.3e-14	873.4483	3	2.3	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-04_FTMSms2hcd	73.359	248	271	47.9	9.3e-14	1.3e-16	1	54530.4	HUMAN	Fascin
[53]		P68431	H31_HUMAN	HIST1H3A	3	19.1	3.45	6.7e-7	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-04_FTMSms2hcd	20.236	42	50	34.0	6.7e-7	1.8e-9	5	15404.2	HUMAN	Histone H3.1
[53]		P68431	H31_HUMAN	HIST1H3A	3	19.1	3.45	6.7e-7	445.9022	3	1.3	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-04_FTMSms2hcd	30.946	74	84	20.6	9.9e-6	1.5e-8	4	15404.2	HUMAN	Histone H3.1
[53]		P68431	H31_HUMAN	HIST1H3A	3	19.1	3.45	6.7e-7	394.7422	2	-0.77	KLPFQR	KLPFQR		6	V20130429-04_FTMSms2hcd	23.229	65	70	20.6	0.051	9.7e-5	5	15404.2	HUMAN	Histone H3.1
[53-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	3.45	6.7e-7	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-04_FTMSms2hcd	20.236	42	50	34.0	6.7e-7	1.8e-9	5	15328.0	HUMAN	Histone H3.3
[53-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	3.45	6.7e-7	445.9022	3	1.3	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-04_FTMSms2hcd	30.946	74	84	20.6	9.9e-6	1.5e-8	4	15328.0	HUMAN	Histone H3.3
[53-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	3.45	6.7e-7	394.7422	2	-0.77	KLPFQR	KLPFQR		6	V20130429-04_FTMSms2hcd	23.229	65	70	20.6	0.051	9.7e-5	5	15328.0	HUMAN	Histone H3.3
[53-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	3.45	6.7e-7	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-04_FTMSms2hcd	20.236	42	50	34.0	6.7e-7	1.8e-9	5	15508.4	HUMAN	Histone H3.1t
[53-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	3.45	6.7e-7	445.9022	3	1.3	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-04_FTMSms2hcd	30.946	74	84	20.6	9.9e-6	1.5e-8	4	15508.4	HUMAN	Histone H3.1t
[53-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	3.45	6.7e-7	394.7422	2	-0.77	KLPFQR	KLPFQR		6	V20130429-04_FTMSms2hcd	23.229	65	70	20.6	0.051	9.7e-5	5	15508.4	HUMAN	Histone H3.1t
[53-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	3.45	6.7e-7	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-04_FTMSms2hcd	20.236	42	50	34.0	6.7e-7	1.8e-9	5	15388.2	HUMAN	Histone H3.2
[53-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	3.45	6.7e-7	445.9022	3	1.3	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-04_FTMSms2hcd	30.946	74	84	20.6	9.9e-6	1.5e-8	4	15388.2	HUMAN	Histone H3.2
[53-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	3.45	6.7e-7	394.7422	2	-0.77	KLPFQR	KLPFQR		6	V20130429-04_FTMSms2hcd	23.229	65	70	20.6	0.051	9.7e-5	5	15388.2	HUMAN	Histone H3.2
[53-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	2	11.1	3.45	6.7e-7	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-04_FTMSms2hcd	20.236	41	49	34.0	6.7e-7	1.8e-9	5	15213.9	HUMAN	Histone H3.3C
[53-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	2	11.1	3.45	6.7e-7	394.7422	2	-0.77	KLPFQR	KLPFQR		6	V20130429-04_FTMSms2hcd	23.229	64	69	20.6	0.051	9.7e-5	5	15213.9	HUMAN	Histone H3.3C
[54]		P05141	ADT2_HUMAN	SLC25A5	2	6.0	3.93	2.2e-9	585.9830	3	-0.30	GMGGAFVLVLYDEIKK	GM(Oxidation)GGAFVLVLYDEIKK	Oxidation@282	16	V20130429-04_FTMSms2hcd	59.904	281	296	25.4	2.2e-9	4.2e-12	3	32852.5	HUMAN	ADP/ATP translocase 2
[54]		P05141	ADT2_HUMAN	SLC25A5	2	6.0	3.93	2.2e-9	1010.5275	2	0.86	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-04_FTMSms2hcd	75.243	281	298	13.9	6.1e-8	8.4e-11	1	32852.5	HUMAN	ADP/ATP translocase 2
[54-1]	0	P12235	ADT1_HUMAN	SLC25A4	1	5.4	3.93	2.2e-9	585.9830	3	-0.30	GMGGAFVLVLYDEIKK	GM(Oxidation)GGAFVLVLYDEIKK	Oxidation@282	16	V20130429-04_FTMSms2hcd	59.904	281	296	25.4	2.2e-9	4.2e-12	3	33064.8	HUMAN	ADP/ATP translocase 1
[54-2]	0	P12236	ADT3_HUMAN	SLC25A6	1	5.4	3.93	2.2e-9	585.9830	3	-0.30	GMGGAFVLVLYDELKK	GM(Oxidation)GGAFVLVLYDELKK	Oxidation@282	16	V20130429-04_FTMSms2hcd	59.904	281	296	25.4	2.2e-9	4.2e-12	3	32866.6	HUMAN	ADP/ATP translocase 3
[55]		P10768	ESTD_HUMAN	ESD	1	7.4	7.01	2.3e-12	863.7519	3	0.11	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-04_FTMSms2hcd	67.926	254	274	46.2	2.3e-12	2.4e-15	1	31463.1	HUMAN	S-formylglutathione hydrolase
[56]		P06732	KCRM_HUMAN	CKM	2	11.8	5.28	1.1e-10	1254.6359	3	2.7	GTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVK	GTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVK		38	V20130429-04_FTMSms2hcd	67.082	321	358	31.9	1.1e-10	1.9e-13	1	43101.5	HUMAN	Creatine kinase M-type
[56]		P06732	KCRM_HUMAN	CKM	2	11.8	5.28	1.1e-10	454.2481	2	0.62	FEEILTR	FEEILTR		7	V20130429-04_FTMSms2hcd	30.147	308	314	29.4	4.5e-4	8.9e-7	1	43101.5	HUMAN	Creatine kinase M-type
[57]		P05387	RLA2_HUMAN	RPLP2	2	28.7	3.74	2.2e-7	724.7094	3	0.87	MRYVASYLLAALGGNSSPSAK	M(Oxidation)RYVASYLLAALGGNSSPSAK	Oxidation@1	21	V20130429-04_FTMSms2hcd	55.265	1	21	24.1	2.2e-7	2.8e-10	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[57]		P05387	RLA2_HUMAN	RPLP2	2	28.7	3.74	2.2e-7	628.8455	2	-0.61	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-04_FTMSms2hcd	47.716	50	61	34.2	1.7e-6	3.1e-9	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[58]		Q15181	IPYR_HUMAN	PPA1	1	13.1	6.89	1.0e-12	1058.5321	4	4.8	VLGILAMIDEGETDWKVIAINVDDPDAANYNDINDVKR	VLGILAM(Oxidation)IDEGETDWKVIAINVDDPDAANYNDINDVKR	Oxidation@146	38	V20130429-04_FTMSms2hcd	69.070	140	177	37.0	1.0e-12	1.8e-15	1	32660.3	HUMAN	Inorganic pyrophosphatase
[59]		P38646	GRP75_HUMAN	HSPA9	1	2.1	6.54	1.7e-11	725.8642	2	2.7	TTPSVVAFTADGER	TTPSVVAFTADGER		14	V20130429-04_FTMSms2hcd	35.876	86	99	40.0	1.7e-11	2.2e-14	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[60]		O75534	CSDE1_HUMAN	CSDE1	1	2.9	6.52	4.2e-12	858.4574	3	3.1	LLPQGTVIFEDISIEHFEGTVTK	LLPQGTVIFEDISIEHFEGTVTK		23	V20130429-04_FTMSms2hcd	64.616	247	269	36.6	4.2e-12	9.0e-15	1	88885.4	HUMAN	Cold shock domain-containing protein E1
[61]		P25205	MCM3_HUMAN	MCM3	1	2.6	6.37	1.1e-11	820.4175	3	1.6	TVDLQDAEEAVELVQYAYFKK	TVDLQDAEEAVELVQYAYFKK		21	V20130429-04_FTMSms2hcd	69.488	636	656	37.2	1.1e-11	1.4e-14	1	90981.6	HUMAN	DNA replication licensing factor MCM3
[62]		P40939	ECHA_HUMAN	HADHA	1	1.8	6.19	8.4e-12	813.9333	2	-2.0	TIEYLEEVAITFAK	TIEYLEEVAITFAK		14	V20130429-04_FTMSms2hcd	66.409	236	249	34.9	8.4e-12	1.5e-14	1	83000.4	HUMAN	Trifunctional enzyme subunit alpha, mitochondrial
[63]		P12268	IMDH2_HUMAN	IMPDH2	1	6.2	6.16	5.3e-12	1093.8691	3	0.47	ALALGASTVMMGSLLAATTEAPGEYFFSDGIR	ALALGASTVM(Oxidation)M(Oxidation)GSLLAATTEAPGEYFFSDGIR	Oxidation@385;Oxidation@386	32	V20130429-04_FTMSms2hcd	68.885	376	407	33.5	5.3e-12	5.4e-15	1	55805.5	HUMAN	Inosine-5'-monophosphate dehydrogenase 2
[64]		P0CG47	UBB_HUMAN	UBB	1	7.0	6.01	1.6e-10	894.4683	2	1.1	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-04_FTMSms2hcd	44.679	12	27	40.5	1.6e-10	2.1e-13	4	25761.8	HUMAN	Polyubiquitin-B
[64-1]	0	P0CG48	UBC_HUMAN	UBC	1	2.3	6.01	1.6e-10	894.4683	2	1.1	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-04_FTMSms2hcd	44.679	12	27	40.5	1.6e-10	2.1e-13	4	77029.2	HUMAN	Polyubiquitin-C
[64-2]	0	P62979	RS27A_HUMAN	RPS27A	1	10.3	6.01	1.6e-10	894.4683	2	1.1	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-04_FTMSms2hcd	44.679	12	27	40.5	1.6e-10	2.1e-13	4	17965.1	HUMAN	Ubiquitin-40S ribosomal protein S27a
[64-3]	0	P62987	RL40_HUMAN	UBA52	1	12.5	6.01	1.6e-10	894.4683	2	1.1	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-04_FTMSms2hcd	44.679	12	27	40.5	1.6e-10	2.1e-13	4	14728.5	HUMAN	Ubiquitin-60S ribosomal protein L40
[65]		P67809	YBOX1_HUMAN	YBX1	1	7.4	5.56	1.8e-11	928.7396	3	-0.33	EDGNEEDKENQGDETQGQQPPQRR	EDGNEEDKENQGDETQGQQPPQRR		24	V20130429-04_FTMSms2hcd	10.363	257	280	30.4	1.8e-11	1.8e-14	1	35924.5	HUMAN	Nuclease-sensitive element-binding protein 1
[66]		P63313	TYB10_HUMAN	TMSB10	1	34.1	5.54	1.2e-9	791.3602	2	1.9	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-04_FTMSms2hcd	31.080	1	15	43.0	1.2e-9	1.6e-12	1	5025.7	HUMAN	Thymosin beta-10
[67]		P21796	VDAC1_HUMAN	VDAC1	1	7.8	5.37	5.5e-11	1217.5974	2	5.2	GALVLGYEGWLAGYQMNFETAK	GALVLGYEGWLAGYQM(Oxidation)NFETAK	Oxidation@155	22	V20130429-04_FTMSms2hcd	64.496	140	161	31.1	5.5e-11	5.8e-14	1	30772.8	HUMAN	Voltage-dependent anion-selective channel protein 1
[68]		P15531	NDKA_HUMAN	NME1	1	7.9	5.34	2.8e-9	672.8854	2	0.083	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-04_FTMSms2hcd	32.145	7	18	41.5	2.8e-9	6.8e-12	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[68-1]	0	P22392	NDKB_HUMAN	NME2	1	7.9	5.34	2.8e-9	672.8854	2	0.083	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-04_FTMSms2hcd	32.145	7	18	41.5	2.8e-9	6.8e-12	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[69]		P11586	C1TC_HUMAN	MTHFD1	1	1.4	5.32	3.1e-9	752.8599	2	-0.023	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-04_FTMSms2hcd	29.933	505	517	45.8	3.1e-9	3.8e-12	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[70]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	5.29	1.8e-10	700.7183	3	1.3	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-04_FTMSms2hcd	70.463	337	355	33.0	1.8e-10	4.3e-13	2	42293.8	HUMAN	Beta-centractin
[70-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	5.29	1.8e-10	700.7183	3	1.3	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-04_FTMSms2hcd	70.463	337	355	33.0	1.8e-10	4.3e-13	2	42614.1	HUMAN	Alpha-centractin
[71]		P09382	LEG1_HUMAN	LGALS1	1	19.3	5.27	1.0e-10	937.4672	3	-7.1	EAVFPFQPGSVAEVCITFDQANLTVK	EAVFPFQPGSVAEVCITFDQANLTVK		26	V20130429-04_FTMSms2hcd	75.829	75	100	31.5	1.0e-10	1.1e-13	1	14715.8	HUMAN	Galectin-1
[72]		P48643	TCPE_HUMAN	CCT5	1	5.2	5.21	5.6e-11	773.4295	4	0.94	VAIEHLDKISDSVLVDIKDTEPLIQTAK	VAIEHLDKISDSVLVDIKDTEPLIQTAK		28	V20130429-04_FTMSms2hcd	60.515	143	170	29.6	5.6e-11	3.1e-13	1	59671.6	HUMAN	T-complex protein 1 subunit epsilon
[73]		P06744	G6PI_HUMAN	GPI	1	2.7	5.20	1.1e-10	860.4788	2	2.4	ILLANFLAQTEALMR	ILLANFLAQTEALM(Oxidation)R	Oxidation@437	15	V20130429-04_FTMSms2hcd	65.874	424	438	31.1	1.1e-10	2.8e-13	1	63147.7	HUMAN	Glucose-6-phosphate isomerase
[74]		P00338	LDHA_HUMAN	LDHA	2	5.4	2.95	2.0e-7	567.7856	2	0.19	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-04_FTMSms2hcd	19.054	306	315	24.1	2.0e-7	3.0e-10	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[74]		P00338	LDHA_HUMAN	LDHA	2	5.4	2.95	2.0e-7	465.2946	2	0.063	FIIPNVVK	FIIPNVVK		8	V20130429-04_FTMSms2hcd	45.308	119	126	26.1	4.6e-6	1.8e-8	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[75]		Q7KZF4	SND1_HUMAN	SND1	1	3.4	5.12	5.6e-10	890.6910	4	-1.6	SASYKPVFVTEITDDLHFYVQDVETGTQLEK	SASYKPVFVTEITDDLHFYVQDVETGTQLEK		31	V20130429-04_FTMSms2hcd	72.129	679	709	34.0	5.6e-10	7.2e-13	1	101997.8	HUMAN	Staphylococcal nuclease domain-containing protein 1
[76]		P56537	IF6_HUMAN	EIF6	1	9.8	5.05	2.2e-10	862.1221	3	2.0	TSIEDQDELSSLLQVPLVAGTVNR	TSIEDQDELSSLLQVPLVAGTVNR		24	V20130429-04_FTMSms2hcd	68.431	165	188	31.1	2.2e-10	4.1e-13	1	26599.3	HUMAN	Eukaryotic translation initiation factor 6
[77]		P26599	PTBP1_HUMAN	PTBP1	1	3.4	5.00	1.8e-10	680.3701	3	-0.14	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-04_FTMSms2hcd	74.923	349	366	30.1	1.8e-10	3.9e-13	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[78]		Q15084	PDIA6_HUMAN	PDIA6	1	3.2	4.98	7.1e-9	693.8839	2	1.3	TGEAIVDAALSALR	TGEAIVDAALSALR		14	V20130429-04_FTMSms2hcd	61.238	119	132	38.6	7.1e-9	1.3e-11	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[79]		Q99832	TCPH_HUMAN	CCT7	1	4.4	4.98	1.4e-10	723.6149	4	-2.9	VHTVEDYQAIVDAEWNILYDKLEK	VHTVEDYQAIVDAEWNILYDKLEK		24	V20130429-04_FTMSms2hcd	68.924	257	280	29.4	1.4e-10	1.6e-13	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[80]		P15880	RS2_HUMAN	RPS2	1	3.8	4.98	1.5e-9	693.8507	2	0.093	TYSYLTPDLWK	TYSYLTPDLWK		11	V20130429-04_FTMSms2hcd	51.419	247	257	35.0	1.5e-9	2.2e-12	1	31324.7	HUMAN	40S ribosomal protein S2
[81]		O00299	CLIC1_HUMAN	CLIC1	1	7.5	4.89	1.1e-10	922.9924	2	1.2	LAALNPESNTAGLDIFAK	LAALNPESNTAGLDIFAK		18	V20130429-04_FTMSms2hcd	54.420	96	113	27.9	1.1e-10	1.8e-13	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[82]		P55084	ECHB_HUMAN	HADHB	1	4.4	4.87	4.1e-9	788.7752	3	2.1	TSVPKEVVDYIIFGTVIQEVK	TSVPKEVVDYIIFGTVIQEVK		21	V20130429-04_FTMSms2hcd	70.355	91	111	36.2	4.1e-9	1.8e-11	1	51294.9	HUMAN	Trifunctional enzyme subunit beta, mitochondrial
[83]		P43487	RANG_HUMAN	RANBP1	1	5.5	4.74	1.4e-8	691.3225	2	0.57	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-04_FTMSms2hcd	44.317	40	50	37.8	1.4e-8	1.9e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[84]		P50990	TCPQ_HUMAN	CCT8	1	3.8	4.62	1.3e-9	806.0409	3	3.1	TAEELMNFSKGEENLMDAQVK	TAEELM(Oxidation)NFSKGEENLM(Oxidation)DAQVK	Oxidation@266;Oxidation@276	21	V20130429-04_FTMSms2hcd	36.858	261	281	31.1	1.3e-9	1.3e-12	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[85]		Q14116	IL18_HUMAN	IL18	1	14.0	4.55	7.0e-10	1072.5038	3	0.79	FIDNTLYFIAEDDENLESDYFGKLESK	FIDNTLYFIAEDDENLESDYFGKLESK		27	V20130429-04_FTMSms2hcd	69.622	18	44	28.9	7.0e-10	7.0e-13	1	22326.4	HUMAN	Interleukin-18
[86]		Q5RI15	FA36A_HUMAN	FAM36A	1	19.5	4.50	6.2e-10	818.1008	3	4.3	HSILYGSLGSVVAGFGHFLFTSR	HSILYGSLGSVVAGFGHFLFTSR		23	V20130429-04_FTMSms2hcd	76.001	32	54	28.1	6.2e-10	1.2e-12	1	13291.3	HUMAN	Protein FAM36A
[87]		P05386	RLA1_HUMAN	RPLP1	1	14.0	4.43	7.6e-10	851.9525	2	1.5	AAGVNVEPFWPGLFAK	AAGVNVEPFWPGLFAK		16	V20130429-04_FTMSms2hcd	64.590	34	49	27.8	7.6e-10	1.1e-12	1	11514.0	HUMAN	60S acidic ribosomal protein P1
[88]		P62847	RS24_HUMAN	RPS24	1	9.0	4.30	8.0e-9	699.8746	2	0.22	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-04_FTMSms2hcd	65.646	50	61	32.1	8.0e-9	1.4e-11	1	15423.3	HUMAN	40S ribosomal protein S24
[89]		Q9UQ80	PA2G4_HUMAN	PA2G4	1	4.6	4.29	4.7e-10	919.3833	2	1.3	TAENATSGETLEENEAGD	TAENATSGETLEENEAGD		18	V20130429-04_FTMSms2hcd	23.110	377	394	25.3	4.7e-10	6.7e-13	1	43787.3	HUMAN	Proliferation-associated protein 2G4
[90]		P23284	PPIB_HUMAN	PPIB	1	6.0	4.28	2.6e-7	682.8571	2	0.95	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-04_FTMSms2hcd	45.494	72	84	42.8	2.6e-7	3.5e-10	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[91]		P05783	K1C18_HUMAN	KRT18	1	8.6	4.26	2.0e-9	1050.5157	4	-5.2	EELDKYWSQQIEESTTVVTTQSAEVGAAETTLTELRR	EELDKYWSQQIEESTTVVTTQSAEVGAAETTLTELRR		37	V20130429-04_FTMSms2hcd	66.892	265	301	28.4	2.0e-9	2.7e-12	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[92]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	4.13	2.4e-8	494.2550	2	0.42	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=16	8	V20130429-04_FTMSms2hcd	30.015	100	107	33.0	2.4e-8	4.3e-11	1	19528.9	HUMAN	MARCKS-related protein
[93]		P14174	MIF_HUMAN	MIF	2	18.3	2.31	1.7e-5	652.3400	2	-7.7	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-04_FTMSms2hcd	36.780	1	12	25.9	1.7e-5	2.3e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[93]		P14174	MIF_HUMAN	MIF	2	18.3	2.31	1.7e-5	494.2869	2	0.97	LLCGLLAER	LLCGLLAER		9	V20130429-04_FTMSms2hcd	46.900	79	87	30.1	1.8e-4	3.1e-7	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[94]		Q09028	RBBP4_HUMAN	RBBP4	1	7.3	4.04	7.8e-8	860.4282	4	-1.6	TIFTGHTAVVEDVSWHLLHESLFGSVADDQK	TIFTGHTAVVEDVSWHLLHESLFGSVADDQK		31	V20130429-04_FTMSms2hcd	67.831	221	251	34.8	7.8e-8	9.3e-11	1	47656.1	HUMAN	Histone-binding protein RBBP4
[95]		P62249	RS16_HUMAN	RPS16	1	6.8	3.98	1.4e-8	547.8641	2	2.3	LLEPVLLLGK	LLEPVLLLGK		10	V20130429-04_FTMSms2hcd	57.171	51	60	30.2	1.4e-8	5.3e-10	1	16445.5	HUMAN	40S ribosomal protein S16
[96]		P46776	RL27A_HUMAN	RPL27A	1	7.4	3.98	1.9e-8	556.3281	2	1.7	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-04_FTMSms2hcd	39.103	95	105	30.9	1.9e-8	1.0e-10	1	16561.5	HUMAN	60S ribosomal protein L27a
[97]		Q9NR30	DDX21_HUMAN	DDX21	1	1.4	3.89	2.9e-7	633.3611	2	0.73	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-04_FTMSms2hcd	62.168	237	247	36.4	2.9e-7	9.5e-10	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[98]		P18206	VINC_HUMAN	VCL	1	2.5	3.68	5.2e-9	780.1476	4	-2.8	TIESILEPVAQQISHLVIMHEEGEVDGK	TIESILEPVAQQISHLVIM(Oxidation)HEEGEVDGK	Oxidation@26	28	V20130429-04_FTMSms2hcd	74.616	8	35	24.8	5.2e-9	7.5e-12	1	123800.4	HUMAN	Vinculin
[99]		Q8NC51	PAIRB_HUMAN	SERBP1	1	5.1	3.53	2.2e-9	1052.4907	2	1.2	TDKSSASAPDVDDPEAFPALA	TDKSSASAPDVDDPEAFPALA		21	V20130429-04_FTMSms2hcd	46.032	388	408	21.4	2.2e-9	2.3e-12	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[100]		P13010	XRCC5_HUMAN	XRCC5	1	1.2	3.53	5.7e-7	516.3099	2	-1.0	TLFPLIEAK	TLFPLIEAK		9	V20130429-04_FTMSms2hcd	51.018	535	543	34.4	5.7e-7	2.5e-9	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[101]		P04083	ANXA1_HUMAN	ANXA1	1	4.0	3.48	3.4e-9	515.2939	3	-1.2	GVDEATIIDILTKR	GVDEATIIDILTKR		14	V20130429-04_FTMSms2hcd	58.763	59	72	21.9	3.4e-9	9.9e-12	1	38714.6	HUMAN	Annexin A1
[102]		P46777	RL5_HUMAN	RPL5	1	6.1	3.48	2.7e-7	624.0007	3	-0.85	VGLTNYAAAYCTGLLLAR	VGLTNYAAAYCTGLLLAR		18	V20130429-04_FTMSms2hcd	67.564	90	107	32.1	2.7e-7	4.8e-10	1	34362.9	HUMAN	60S ribosomal protein L5
[103]		P46778	RL21_HUMAN	RPL21	1	11.2	3.42	6.0e-8	1047.5101	2	1.4	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-04_FTMSms2hcd	57.504	143	160	28.0	6.0e-8	6.0e-11	1	18565.0	HUMAN	60S ribosomal protein L21
[104]		O60361	NDK8_HUMAN	NME2P1	1	7.3	3.33	1.7e-8	423.2242	3	0.92	FKPEELVDYK	FKPEELVDYK		10	V20130429-04_FTMSms2hcd	35.717	119	128	24.2	1.7e-8	2.4e-11	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[105]		P15259	PGAM2_HUMAN	PGAM2	1	5.5	3.17	7.0e-8	842.4637	2	5.7	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-04_FTMSms2hcd	62.181	163	176	25.9	7.0e-8	1.5e-10	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[105-1]	0	P18669	PGAM1_HUMAN	PGAM1	1	5.5	3.17	7.0e-8	842.4637	2	5.7	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-04_FTMSms2hcd	62.181	163	176	25.9	7.0e-8	1.5e-10	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[105-2]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	1	5.5	3.17	7.0e-8	842.4637	2	5.7	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-04_FTMSms2hcd	62.181	163	176	25.9	7.0e-8	1.5e-10	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[106]		Q00839	HNRPU_HUMAN	HNRNPU	1	3.3	3.03	1.1e-8	1044.1720	3	2.9	GNFTLPEVAECFDEITYVELQKEEAQK	GNFTLPEVAECFDEITYVELQKEEAQK		27	V20130429-04_FTMSms2hcd	74.533	638	664	20.1	1.1e-8	1.1e-11	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[107]		O76003	GLRX3_HUMAN	GLRX3	1	8.7	2.93	5.9e-8	1127.5785	3	3.0	QILEILNSTGVEYETFDILEDEEVRQGLK	QILEILNSTGVEYETFDILEDEEVRQGLK		29	V20130429-04_FTMSms2hcd	71.698	266	294	23.1	5.9e-8	1.0e-10	1	37432.4	HUMAN	Glutaredoxin-3
[108]		P13804	ETFA_HUMAN	ETFA	1	7.8	2.90	5.9e-8	675.1237	4	3.2	IVAPELYIAVGISGAIQHLAGMKDSK	IVAPELYIAVGISGAIQHLAGM(Oxidation)KDSK	Oxidation@290	26	V20130429-04_FTMSms2hcd	74.737	269	294	22.7	5.9e-8	2.2e-10	1	35079.9	HUMAN	Electron transfer flavoprotein subunit alpha, mitochondrial
[109]		Q9Y490	TLN1_HUMAN	TLN1	1	0.6	2.69	4.9e-7	761.4286	2	-1.6	TLAESALQLLYTAK	TLAESALQLLYTAK		14	V20130429-04_FTMSms2hcd	62.689	1767	1780	25.6	4.9e-7	1.3e-9	1	269769.4	HUMAN	Talin-1
[110]		O75531	BAF_HUMAN	BANF1	1	13.5	2.64	6.2e-7	675.4129	2	-0.45	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-04_FTMSms2hcd	64.242	42	53	25.7	6.2e-7	9.8e-9	1	10058.7	HUMAN	Barrier-to-autointegration factor
[111]		P60842	IF4A1_HUMAN	EIF4A1	1	5.9	2.63	1.5e-7	938.4698	3	1.2	TLRDIETFYNTSIEEMPLNVADLI	TLRDIETFYNTSIEEM(Oxidation)PLNVADLI	Oxidation@398	24	V20130429-04_FTMSms2hcd	73.466	383	406	22.2	1.5e-7	1.8e-10	1	46154.4	HUMAN	Eukaryotic initiation factor 4A-I
[112]		P62851	RS25_HUMAN	RPS25	1	7.2	2.22	5.7e-5	486.7904	2	1.1	AALQELLSK	AALQELLSK		9	V20130429-04_FTMSms2hcd	39.439	86	94	32.1	5.7e-5	1.2e-7	1	13742.2	HUMAN	40S ribosomal protein S25
[113]		P62701	RS4X_HUMAN	RPS4X	2	7.6	2.06	5.1e-6	495.8026	2	-0.32	LSNIFVIGK	LSNIFVIGK		9	V20130429-04_FTMSms2hcd	44.851	222	230	24.8	5.1e-6	3.2e-8	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[113]		P62701	RS4X_HUMAN	RPS4X	2	7.6	2.06	5.1e-6	405.8914	3	0.30	GIPHLVTHDAR	GIPHLVTHDAR		11	V20130429-04_FTMSms2hcd	16.216	135	145	12.2	0.017	2.8e-5	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[114]		P0CG39	POTEJ_HUMAN	POTEJ	1	1.7	2.19	5.6e-7	656.6866	3	-18	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-04_FTMSms2hcd	41.065	759	776	20.9	5.6e-7	1.1e-9	4	117391.0	HUMAN	POTE ankyrin domain family member J
[115]		O60841	IF2P_HUMAN	EIF5B	1	1.9	2.17	9.1e-7	869.7900	3	-0.43	AIIVEFAQQGLNAALFYENKDPR	AIIVEFAQQGLNAALFYENKDPR		23	V20130429-04_FTMSms2hcd	65.887	793	815	21.9	9.1e-7	1.6e-9	1	138828.0	HUMAN	Eukaryotic translation initiation factor 5B
[116]		O00764	PDXK_HUMAN	PDXK	1	6.7	2.17	5.5e-7	761.4200	3	2.8	VVPLADIITPNQFEAELLSGR	VVPLADIITPNQFEAELLSGR		21	V20130429-04_FTMSms2hcd	73.652	140	160	20.7	5.5e-7	1.7e-9	1	35102.6	HUMAN	Pyridoxal kinase
[117]		P60660	MYL6_HUMAN	MYL6	1	10.6	2.16	8.0e-7	635.3394	3	2.6	VLDFEHFLPMLQTVAK	VLDFEHFLPM(Oxidation)LQTVAK	Oxidation@73	16	V20130429-04_FTMSms2hcd	63.398	64	79	21.5	8.0e-7	1.2e-9	1	16930.2	HUMAN	Myosin light polypeptide 6
[118]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	2.08	1.7e-6	610.8142	2	1.6	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-04_FTMSms2hcd	37.585	1959	1968	22.4	1.7e-6	2.4e-9	1	333188.0	HUMAN	WD repeat-containing protein 87
[119]		P02768	ALBU_HUMAN	ALB	2	2.3	0.99	0.0030	395.2397	2	0.60	LVTDLTK	LVTDLTK		7	V20130429-04_FTMSms2hcd	21.990	258	264	29.1	0.0030	8.6e-6	1	69367.4	HUMAN	Serum albumin
[119]		P02768	ALBU_HUMAN	ALB	2	2.3	0.99	0.0030	464.2510	2	1.4	YLYEIAR	YLYEIAR		7	V20130429-04_FTMSms2hcd	31.162	162	168	27.0	0.0037	9.1e-6	1	69367.4	HUMAN	Serum albumin
[120]		P46783	RS10_HUMAN	RPS10	1	5.5	1.70	6.3e-5	555.3333	2	-1.1	IAIYELLFK	IAIYELLFK		9	V20130429-04_FTMSms2hcd	65.069	9	17	27.1	6.3e-5	4.0e-7	1	18897.9	HUMAN	40S ribosomal protein S10
[121]		P29401	TKT_HUMAN	TKT	1	2.7	1.58	4.5e-6	680.3438	3	2.7	NMAEQIIQEIYSQIQSK	NM(Oxidation)AEQIIQEIYSQIQSK	Oxidation@266	17	V20130429-04_FTMSms2hcd	69.446	265	281	19.7	4.5e-6	5.3e-9	1	67878.2	HUMAN	Transketolase
[122]		O95025	SEM3D_HUMAN	SEMA3D	1	1.5	1.56	4.7e-6	738.3115	2	0.23	IPYPRPGTCPSK	IPY(Phospho)PRPGTCPS(Phospho)K	Phospho@392=8;Phospho@397|400	12	V20130429-04_FTMSms2hcd	16.147	390	401	19.6	4.7e-6	7.8e-9	1	89652.1	HUMAN	Semaphorin-3D
[123]		Q12882	DPYD_HUMAN	DPYD	1	1.5	1.46	3.3e-4	920.4256	2	12	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-04_FTMSms2hcd	28.445	260	274	28.6	3.3e-4	3.6e-7	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[124]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.19	0.0052	435.2583	2	0.26	LEPLLER	LEPLLER		7	V20130429-04_FTMSms2hcd	30.811	769	775	32.4	0.0052	2.3e-5	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[125]		O14979	HNRDL_HUMAN	HNRPDL	1	1.9	1.11	8.4e-5	457.7603	2	-0.14	GFGFVLFK	GFGFVLFK		8	V20130429-04_FTMSms2hcd	57.598	190	197	21.9	8.4e-5	2.2e-7	2	46437.9	HUMAN	Heterogeneous nuclear ribonucleoprotein D-like
[125-1]	0	Q14103	HNRPD_HUMAN	HNRNPD	1	2.3	1.11	8.4e-5	457.7603	2	-0.14	GFGFVLFK	GFGFVLFK		8	V20130429-04_FTMSms2hcd	57.598	139	146	21.9	8.4e-5	2.2e-7	2	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[126]		P04075	ALDOA_HUMAN	ALDOA	1	3.8	1.09	1.5e-4	823.9103	2	2.5	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-04_FTMSms2hcd	16.241	44	57	23.1	1.5e-4	1.8e-7	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[127]		P06576	ATPB_HUMAN	ATP5B	1	4.5	1.08	3.0e-5	897.7933	3	-3.8	SLQDIIAILGMDELSEEDKLTVSR	SLQDIIAILGM(Oxidation)DELSEEDKLTVSR	Oxidation@443	24	V20130429-04_FTMSms2hcd	72.612	433	456	19.2	3.0e-5	3.9e-8	1	56560.4	HUMAN	ATP synthase subunit beta, mitochondrial
[128]		Q4G0M1	F132B_HUMAN	FAM132B	1	4.0	1.08	7.9e-5	750.3648	2	15	AGPAARPPEPTAER	AGPAARPPEPT(Phospho)AER	Phospho@69	14	V20130429-04_FTMSms2hcd	24.654	59	72	21.4	7.9e-5	9.5e-8	1	37279.2	HUMAN	Protein FAM132B
[129]		Q8TEM1	PO210_HUMAN	NUP210	1	0.5	1.07	1.3e-5	511.2883	2	1.6	VPVVHVDEK	VPVVHVDEK		9	V20130429-04_FTMSms2hcd	35.982	1329	1337	17.1	1.3e-5	3.6e-8	1	205112.9	HUMAN	Nuclear pore membrane glycoprotein 210
[130]		P07237	PDIA1_HUMAN	P4HB	1	3.0	1.07	1.0e-5	917.4553	2	-5.3	ILFIFIDSDHTDNQR	ILFIFIDSDHTDNQR		15	V20130429-04_FTMSms2hcd	54.381	286	300	16.5	1.0e-5	1.1e-8	1	57116.8	HUMAN	Protein disulfide-isomerase
[131]		P25398	RS12_HUMAN	RPS12	1	17.4	1.05	1.3e-5	758.3815	3	-1.3	MAEEGIAAGGVMDVNTALQEVLK	M(Met-loss+Acetyl)AEEGIAAGGVM(Oxidation)DVNTALQEVLK	Met-loss+Acetyl@1;Oxidation@12	23	V20130429-04_FTMSms2hcd	71.940	1	23	16.8	1.3e-5	1.5e-8	1	14515.1	HUMAN	40S ribosomal protein S12
[132]		Q68DN1	CB016_HUMAN	C2orf16	2	0.6	0.88	1.1e-5	473.1902	3	10	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)T(Phospho)ASLK	Phospho@1332=6;Phospho@1333=6;Phospho@1334=6	12	V20130429-04_FTMSms2hcd	14.757	1327	1338	11.1	1.1e-5	2.8e-8	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[132]		Q68DN1	CB016_HUMAN	C2orf16	2	0.6	0.88	1.1e-5	709.2819	2	11	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)TAS(Phospho)LK	Phospho@1332&1333&1334|1332&1333&1336|1332&1334&1336|1333&1334&1336	12	V20130429-04_FTMSms2hcd	14.731	1327	1338	14.8	2.8e-4	7.2e-7	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[133]		Q14847	LASP1_HUMAN	LASP1	1	5.7	1.00	4.3e-6	784.3682	2	-1.1	TGDTGMLPANYVEAI	TGDTGM(Oxidation)LPANYVEAI	Oxidation@252	15	V20130429-04_FTMSms2hcd	48.609	247	261	13.8	4.3e-6	5.3e-9	1	29717.4	HUMAN	LIM and SH3 domain protein 1
[134]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.98	4.6e-5	668.3290	2	12	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-04_FTMSms2hcd	30.053	376	386	19.2	4.6e-5	6.7e-8	1	46099.6	HUMAN	Zinc finger protein 763
[135]		Q8N187	AL2S8_HUMAN	ALS2CR8	1	1.0	0.95	2.6e-5	464.2021	2	4.1	VETNQTR	VETNQT(Phospho)R	Phospho@536=26	7	V20130429-04_FTMSms2hcd	13.962	531	537	17.6	2.6e-5	6.5e-8	1	80698.6	HUMAN	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein
[136]		P49321	NASP_HUMAN	NASP	1	3.0	0.87	6.9e-4	935.7843	3	8.9	SLQENEEEEIGNLELAWDMLDLAK	SLQENEEEEIGNLELAWDM(Oxidation)LDLAK	Oxidation@521	24	V20130429-04_FTMSms2hcd	72.866	503	526	24.4	6.9e-4	6.6e-7	1	85238.4	HUMAN	Nuclear autoantigenic sperm protein
[137]		Q9Y6A5	TACC3_HUMAN	TACC3	1	0.8	0.83	0.0027	433.2247	2	0.83	EVIEGYR	EVIEGYR		7	V20130429-04_FTMSms2hcd	19.253	734	740	27.3	0.0027	5.7e-6	1	90360.4	HUMAN	Transforming acidic coiled-coil-containing protein 3
[138]		O43175	SERA_HUMAN	PHGDH	1	1.7	0.74	0.0020	450.2872	2	-0.17	TLGILGLGR	TLGILGLGR		9	V20130429-04_FTMSms2hcd	46.153	147	155	25.6	0.0020	8.4e-6	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[139]		P41250	SYG_HUMAN	GARS	1	1.8	0.73	2.1e-5	729.3958	2	1.1	TFFSFPAVVAPFK	TFFSFPAVVAPFK		13	V20130429-04_FTMSms2hcd	67.267	603	615	14.8	2.1e-5	3.7e-8	1	83166.3	HUMAN	Glycine--tRNA ligase
[140]		P62753	RS6_HUMAN	RPS6	1	3.2	0.71	1.4e-4	494.7510	2	0.16	LIEVDDER	LIEVDDER		8	V20130429-04_FTMSms2hcd	22.155	15	22	19.1	1.4e-4	2.7e-7	1	28680.9	HUMAN	40S ribosomal protein S6
[141]		P52565	GDIR1_HUMAN	ARHGDIA	1	7.4	0.65	1.9e-5	876.4300	2	8.7	AEEYEFLTPVEEAPK	AEEYEFLTPVEEAPK		15	V20130429-04_FTMSms2hcd	46.861	153	167	13.8	1.9e-5	2.1e-8	1	23207.3	HUMAN	Rho GDP-dissociation inhibitor 1
[142]		P08069	IGF1R_HUMAN	IGF1R	1	0.5	0.62	4.5e-5	523.7291	2	5.2	YRPPDYR	YRPPDY(Phospho)R	Phospho@517=44	7	V20130429-04_FTMSms2hcd	15.715	512	518	15.5	4.5e-5	9.5e-8	1	154794.5	HUMAN	Insulin-like growth factor 1 receptor
[143]		Q9H2G4	TSYL2_HUMAN	TSPYL2	1	1.0	0.59	0.0023	414.7685	2	-0.53	ISILINR	ISILINR		7	V20130429-04_FTMSms2hcd	37.543	276	282	24.4	0.0023	7.8e-6	1	79435.7	HUMAN	Testis-specific Y-encoded-like protein 2
[144]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.58	0.032	665.3600	2	-5.1	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-04_FTMSms2hcd	19.656	311	322	30.6	0.032	5.4e-5	1	37425.1	HUMAN	Transmembrane protein 68
[145]		Q8N3U4	STAG2_HUMAN	STAG2	1	0.8	0.58	8.1e-4	617.8666	2	-9.7	HLDALLRQIR	HLDALLRQIR		10	V20130429-04_FTMSms2hcd	47.168	608	617	21.9	8.1e-4	3.9e-6	1	141327.7	HUMAN	Cohesin subunit SA-2
[146]		O95466	FMNL_HUMAN	FMNL1	1	0.9	0.54	0.0015	569.2691	2	0.83	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-04_FTMSms2hcd	16.734	622	631	22.9	0.0015	2.6e-6	1	121854.6	HUMAN	Formin-like protein 1
[147]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.52	0.0020	416.7418	2	-1.4	GVLSDLTK	GVLSDLTK		8	V20130429-04_FTMSms2hcd	44.972	45	52	23.5	0.0020	3.7e-6	1	30691.1	HUMAN	Tetraspanin-14
[148]		Q15417	CNN3_HUMAN	CNN3	1	4.3	0.50	8.3e-5	776.8263	2	3.7	CASQAGMTAYGTRR	CAS(Phospho)QAGMTAYGTRR	Phospho@175=16	14	V20130429-04_FTMSms2hcd	10.494	173	186	15.8	8.3e-5	1.5e-7	1	36414.0	HUMAN	Calponin-3
[149]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	0.45	1.2e-4	723.3577	2	2.2	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=16	11	V20130429-04_FTMSms2hcd	42.875	1367	1377	16.1	1.2e-4	1.5e-7	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[150]		O75400	PR40A_HUMAN	PRPF40A	1	1.0	0.44	1.9e-4	595.2849	2	3.6	TLLEQLDDDQ	TLLEQLDDDQ		10	V20130429-04_FTMSms2hcd	43.370	948	957	17.1	1.9e-4	3.0e-7	1	108805.9	HUMAN	Pre-mRNA-processing factor 40 homolog A
[151]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.43	0.0010	426.2718	2	1.7	HILDIIK	HILDIIK		7	V20130429-04_FTMSms2hcd	36.422	994	1000	21.0	0.0010	1.4e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[152]		Q4G0P3	HYDIN_HUMAN	HYDIN	1	0.2	0.40	5.9e-4	649.8417	2	7.2	LPPELYEYFK	LPPELYEYFK		10	V20130429-04_FTMSms2hcd	44.120	1898	1907	19.4	5.9e-4	9.4e-7	1	575897.1	HUMAN	Hydrocephalus-inducing protein homolog
[153]		O75947	ATP5H_HUMAN	ATP5H	1	9.9	0.39	3.9e-5	936.9966	2	0.27	TIDWVAFAEIIPQNQK	TIDWVAFAEIIPQNQK		16	V20130429-04_FTMSms2hcd	66.194	10	25	12.9	3.9e-5	6.5e-8	1	18491.4	HUMAN	ATP synthase subunit d, mitochondrial
[154]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	0.35	3.4e-4	695.3214	2	0.15	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-04_FTMSms2hcd	25.234	166	177	17.6	3.4e-4	4.7e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[155]		Q7RTY7	OVCH1_HUMAN	OVCH1	1	1.1	0.32	2.8e-4	727.3215	2	-9.0	LPPQNNPVSTVK	LPPQNNPVS(Phospho)T(Phospho)VK	Phospho@551;Phospho@552	12	V20130429-04_FTMSms2hcd	16.076	543	554	16.8	2.8e-4	4.3e-7	1	125067.2	HUMAN	Ovochymase-1
[156]		Q8N3X6	LCORL_HUMAN	LCORL	1	1.8	0.32	2.8e-4	727.3215	2	7.2	IPQLRVSSVSK	IPQLRVS(Phospho)S(Phospho)VS(Phospho)K	Phospho@420;Phospho@421;Phospho@423	11	V20130429-04_FTMSms2hcd	16.076	414	424	16.8	2.8e-4	4.3e-7	1	66964.2	HUMAN	Ligand-dependent nuclear receptor corepressor-like protein
[157]		Q8NF50	DOCK8_HUMAN	DOCK8	1	0.6	0.32	2.8e-4	727.3215	2	12	LPPNYSMHSAEK	LPPNYS(Phospho)MHSAEK	Phospho@698|701	12	V20130429-04_FTMSms2hcd	16.076	693	704	16.8	2.8e-4	4.3e-7	1	238531.2	HUMAN	Dedicator of cytokinesis protein 8
[158]		Q96PL5	ERMAP_HUMAN	ERMAP	1	8.2	0.30	2.7e-4	1004.5349	4	13	LSVHVSGHAGDAGKFHVALLGGTAELLCPLSLWPGTVPK	LSVHVSGHAGDAGKFHVALLGGT(Phospho)AELLCPLSLWPGTVPK	Phospho@24|28|45	39	V20130429-04_FTMSms2hcd	63.238	23	61	16.6	2.7e-4	1.1e-6	1	52605.2	HUMAN	Erythroid membrane-associated protein
[159]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.30	0.0068	564.3173	2	-0.58	RQVAEANALR	RQVAEANALR		10	V20130429-04_FTMSms2hcd	15.917	776	785	24.1	0.0068	1.9e-5	1	161604.6	HUMAN	Centlein
[160]		P25685	DNJB1_HUMAN	DNAJB1	1	2.6	0.25	4.4e-5	506.3075	2	-0.74	TVLEQVLPI	TVLEQVLPI		9	V20130429-04_FTMSms2hcd	59.943	332	340	11.7	4.4e-5	2.9e-7	1	38044.4	HUMAN	DnaJ homolog subfamily B member 1
[161]		P13667	PDIA4_HUMAN	PDIA4	1	2.0	0.23	4.7e-4	751.8785	2	18	FEGGDRDLEHLSK	FEGGDRDLEHLSK		13	V20130429-04_FTMSms2hcd	37.369	617	629	17.2	4.7e-4	6.5e-7	1	72933.1	HUMAN	Protein disulfide-isomerase A4
[162]		Q9BTC8	MTA3_HUMAN	MTA3	1	2.0	0.22	6.4e-4	698.8507	2	7.8	STPSLQTPTTKR	STPSLQT(Phospho)PTTKR	Phospho@556|558|559	12	V20130429-04_FTMSms2hcd	15.843	550	561	17.8	6.4e-4	7.5e-7	1	67504.3	HUMAN	Metastasis-associated protein MTA3
[163]		Q08257	QOR_HUMAN	CRYZ	1	3.3	0.21	0.0022	407.8881	3	-1.4	VFEFGGPEVLK	VFEFGGPEVLK		11	V20130429-04_FTMSms2hcd	18.492	13	23	20.6	0.0022	3.8e-6	1	35206.9	HUMAN	Quinone oxidoreductase
[164]		O94772	LY6H_HUMAN	LY6H	1	9.3	0.18	8.7e-5	728.7958	2	17	QCQPSDTVCASVR	Q(Gln->pyro-Glu)CQPSDTVCAS(Phospho)VR	Gln->pyro-Glu@44;Phospho@54=10	13	V20130429-04_FTMSms2hcd	9.514	44	56	12.7	8.7e-5	1.9e-7	1	14669.2	HUMAN	Lymphocyte antigen 6H
[165]		Q03938	ZNF90_HUMAN	ZNF90	1	1.7	0.17	2.7e-4	611.3209	2	-0.48	LSSILSTHKR	LSSILST(Phospho)HKR	Phospho@329|330	10	V20130429-04_FTMSms2hcd	51.380	324	333	15.2	2.7e-4	4.0e-7	1	69058.3	HUMAN	Zinc finger protein 90
[166]		Q9H2D6	TARA_HUMAN	TRIOBP	1	0.3	0.17	0.0014	488.2709	2	-1.2	LSEEIEKK	LSEEIEKK		8	V20130429-04_FTMSms2hcd	28.580	2022	2029	19.1	0.0014	2.5e-6	1	261377.7	HUMAN	TRIO and F-actin-binding protein
[167]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.13	1.6e-4	646.3254	2	-2.2	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-04_FTMSms2hcd	55.157	1	11	13.6	1.6e-4	2.2e-7	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[168]		Q8N4V2	SVOP_HUMAN	SVOP	1	1.6	0.11	9.5e-5	605.2986	2	-7.3	LIISRQEDR	LIIS(Phospho)RQEDR	Phospho@297	9	V20130429-04_FTMSms2hcd	68.764	294	302	12.2	9.5e-5	1.1e-7	1	60769.7	HUMAN	Synaptic vesicle 2-related protein
[169]		Q14008	CKAP5_HUMAN	CKAP5	1	1.1	0.11	6.5e-5	807.7991	3	-2.9	ILVQQTLNILQQLAVAMGPNIK	ILVQQTLNILQQLAVAM(Oxidation)GPNIK	Oxidation@931	22	V20130429-04_FTMSms2hcd	74.005	915	936	11.3	6.5e-5	6.4e-7	1	225496.6	HUMAN	Cytoskeleton-associated protein 5
[170]		P62826	RAN_HUMAN	RAN	1	6.5	0.11	1.2e-4	595.6423	3	0.27	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-04_FTMSms2hcd	58.254	153	166	12.7	1.2e-4	1.7e-7	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[171]		Q6ZVZ8	ASB18_HUMAN	ASB18	1	4.9	0.09	0.0013	1106.0575	2	13	GAHVDARNGRGETALSAACGAAR	GAHVDARNGRGETALSAACGAAR		23	V20130429-04_FTMSms2hcd	45.719	242	264	18.2	0.0013	1.5e-6	1	50803.8	HUMAN	Ankyrin repeat and SOCS box protein 18
[172]		Q9C0D5	TANC1_HUMAN	TANC1	1	0.9	0.09	0.0024	704.9969	3	-7.5	FPREGFGEDMRPFNELR	FPREGFGEDM(Oxidation)RPFNELR	Oxidation@1328	17	V20130429-04_FTMSms2hcd	55.809	1319	1335	19.5	0.0024	2.4e-6	1	202221.0	HUMAN	Protein TANC1
[173]		Q9Y5S1	TRPV2_HUMAN	TRPV2	1	1.4	0.07	0.028	643.8460	2	5.8	LCPTVQLEDIR	LCPTVQLEDIR		11	V20130429-04_FTMSms2hcd	15.448	280	290	25.1	0.028	4.4e-5	1	85981.9	HUMAN	Transient receptor potential cation channel subfamily V member 2
[174]		Q9H3R0	KDM4C_HUMAN	KDM4C	1	1.2	0.01	8.5e-5	740.3210	2	7.8	RVSGACIQCSYGR	RVSGACIQCSY(Phospho)GR	Phospho@829=8	13	V20130429-04_FTMSms2hcd	31.799	819	831	10.9	8.5e-5	1.4e-7	1	119982.9	HUMAN	Lysine-specific demethylase 4C
[175]		Q496Y0	LONF3_HUMAN	LONRF3	1	1.6	0.01	6.3e-4	735.8724	2	-11	AQLPFLAMRSLK	AQLPFLAM(Oxidation)RS(Phospho)LK	Oxidation@737;Phospho@739	12	V20130429-04_FTMSms2hcd	62.155	730	741	15.6	6.3e-4	8.1e-7	1	84490.4	HUMAN	LON peptidase N-terminal domain and RING finger protein 3
